The University of Queensland

A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care

Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Bernard, Anne, Brown, Nigel Neil, Lampe, Guy, Buck, Lyndall, Saad, Nivene, Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Rosenberg, William and Powell, Elizabeth Ellen (2018). A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatology Communications, 2 (8), 893-905. doi: 10.1002/hep4.1208

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath, Divya, Irvine, Katharine M., Lukowski, Samuel W., Horsfall, Leigh U., Loh, Zhixuan, Clouston, Andrew D., Patel, Preya J., Fagan, Kevin J., Iyer, Abishek, Lampe, Guy, Stow, Jennifer L., Schroder, Kate, Fairlie, David P., Powell, Joseph E., Powell, Elizabeth E. and Sweet, Matthew J. (2018). Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight, 3 (14). doi: 10.1172/jci.insight.120274

Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis

Patel, Preya J., Banh, Xuan, Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew, Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C., Williams, Suzanne and Powell, Elizabeth E (2018). Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Medicine Journal, 48 (2), 144-151. doi: 10.1111/imj.13667

Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis

Maradana, Muralidhara Rao, Yekollu, Suman Kumar, Zeng, Bijun, Ellis, Jonathan, Clouston, Andrew, Miller, Gregory, Talekar, Meghna, Bhuyan, Zaied Ahmed, Mahadevaiah, Sachin, Powell, Elizabeth E., Irvine, Katharine M., Thomas, Ranjeny and O'Sullivan, Brendan John (2018). Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism: Clinical and Experimental, 78, 80-94. doi: 10.1016/j.metabol.2017.09.002

Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease

Patel, Preya J., Smith, David, Connor, Jason P., Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew D., Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C. and Powell, Elizabeth E. (2017). Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease. Canadian Journal of Gastroenterology and Hepatology, 2017 7927685, 7927685-8. doi: 10.1155/2017/7927685

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

Hayward, Kelly L., Valery, Patricia C., Martin, Jennifer H., Karmakar, Antara, Patel, Preya J., Horsfall, Leigh U., Tallis, Caroline J., Stuart, Katherine A., Wright, Penny L., Smith, David D., Irvine, Katharine M., Powell, Elizabeth E. and Cottrell, W. Neil (2017). Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World Journal of Gastroenterology, 23 (40), 7321-7331. doi: 10.3748/wjg.v23.i40.7321

Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management

Hayward, Kelly L., Horsfall, Leigh U., Ruffin, Brittany J., Cottrell, W. Neil, Chachay, Veronique S., Irvine, Katharine M., Martin, Jennifer H., Powell, Elizabeth E. and Valery, Patricia C. (2017). Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management. Internal Medicine Journal, 47 (8), 952-955. doi: 10.1111/imj.13505

Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management

Patel, Preya Janubhai, Hayward, Kelly Lee, Rudra, Rathiga, Horsfall, Leigh Ula, Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Clouston, Andrew Donald, Stuart, Katherine Anne, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Russell, Anthony William and Powell, Elizabeth Ellen (2017). Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management. Medicine, 96 (26) e6761, e6761. doi: 10.1097/MD.0000000000006761

Identifying areas of need relative to liver disease: geographic clustering within a health service district

El-Atem, Nathan, Irvine, Katharine M., Valery, Patricia C., Wojcik, Kyle, Horsfall, Leigh, Johnson, Tracey, Janda, Monika, McPhail, Steven M. and Powell, Elizabeth E. (2017). Identifying areas of need relative to liver disease: geographic clustering within a health service district. Australian Health Review, 41 (4), 407-418. doi: 10.1071/AH15225

Does NASH or NAFLD Contribute to Comorbidity of Other Liver Diseases?

Clouston, Andrew D. and Powell, Elizabeth E. (2007). Does NASH or NAFLD Contribute to Comorbidity of Other Liver Diseases?. Fatty Liver Disease: NASH and Related Disorders. (pp. 276-288) Oxford, UK: wiley. doi: 10.1002/9780470987438.ch23

Fatty liver as a cofactor for other liver diseases

McPherson, S., Clouston, A.D., Jonsson, J.R. and Powell, E. (2007). Fatty liver as a cofactor for other liver diseases. International Hepatology Updates: Nonalcoholic steatohepatitis (NASH). (pp. 161-174) edited by Bataller, R. and Caballeria, J.. Spain: Permanyer Publications.

Does NASH or NAFLD contribute to comorbidity of other liver diseases?

Powell, Elizabeth E. (2005). Does NASH or NAFLD contribute to comorbidity of other liver diseases?. Fatty liver disease: NASH and related disorders. (pp. 276-288) edited by Geoffrey C. Farrell, Jacob George, Pauline de la M. Hall and Arthur J. McCullough. Oxford, United Kingdom: Blackwell.

A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia

Senanayake, S., Barnett, A., Brain, D., Allen, M., Powell, E.E., O'Beirne, J., Valery, P., Hickman, I.J. and Kularatna, S. (2024). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia. Public Health, 228, 105-111. doi: 10.1016/j.puhe.2024.01.007

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Rinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Narro, Graciela E. Castro, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2024). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Annals of Hepatology, 29 (1) 101133, 101133. doi: 10.1016/j.aohep.2023.101133

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

Gracen, Lucy, Muthukumara, Withma, Aikebuse, Melanie, Russell, Anthony, O'Beirne, James, Irvine, Katharine M., Williams, Suzanne, Puri, Gaurav, Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2023). Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists. Annals of Hepatology, 28 (6) 101142, 101142. doi: 10.1016/j.aohep.2023.101142

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics

Huang, Gary, Wallace, Daniel F., Powell, Elizabeth E., Rahman, Tony, Clark, Paul J. and Subramaniam, V. Nathan (2023). Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. Biomedicines, 11 (10) 2809, 2809. doi: 10.3390/biomedicines11102809

Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data

Hayward, Kelly L., Weersink, Rianne A., Bernardes, Christina M., McIvor, Carolyn, Rahman, Tony, Skoien, Richard, Clark, Paul J., Stuart, Katherine A., Hartel, Gunter, Valery, Patricia C. and Powell, Elizabeth E. (2023). Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data. Drugs - Real World Outcomes, 10 (4), 1-14. doi: 10.1007/s40801-023-00390-2

Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study

O'Beirne, James, Skoien, Richard, Leggett, Barbara A., Hartel, Gunter F., Gordon, Louisa G., Powell, Elizabeth E. and Valery, Patricia C. (2023). Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study. Medical Journal of Australia, 219 (8), 358-365. doi: 10.5694/mja2.52104

A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels

Allen, Michelle J, Doran, Rachael, Brain, David, Powell, Elizabeth E, O’Beirne, James, Valery, Patricia C, Barnett, Adrian, Hettiarachchi, Ruvini, Hickman, Ingrid J and Kularatna, Sanjeewa (2023). A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Services Research, 23 (1) 950, 1-12. doi: 10.1186/s12913-023-09934-2

Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?

Valery, Patricia C. and Powell, Elizabeth E. (2023). Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?. The Lancet Gastroenterology and Hepatology, 8 (8), 684-685. doi: 10.1016/s2468-1253(23)00149-8

Social networks and citizenship behavior: the mediating effect of organizational identification

Zagenczyk, Thomas J. and Powell, E. Erin (2023). Social networks and citizenship behavior: the mediating effect of organizational identification. Human Resource Management, 62 (4), 461-475. doi: 10.1002/hrm.22144

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Rinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Pablo Arab, Juan, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78 (6), 1966-1986. doi: 10.1097/HEP.0000000000000520

Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory study

Amarasena, Samath, Clark, Paul J., Gordon, Louisa G., Toombs, Maree, Pratt, Greg, Hartel, Gunter, Bernardes, Christina M., Powell, Elizabeth E. and Valery, Patricia C. (2023). Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory study. Internal Medicine Journal, 53 (6), 961-969. doi: 10.1111/imj.15854

Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort study

Hong, Zhen Howe, Johnson, Stephanie, Ha, Tina, McIvor, Carolyn, Stuart, Katherine, Valery, Patricia, Powell, Elizabeth and Hayward, Kelly (2023). Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort study. Journal of Hepatology, 78, S239. doi: 10.1016/s0168-8278(23)00794-8

Low prevalence of use of allied health and community services for patients with cirrhosis in Australia: a need for greater engagement

Powell, Elizabeth E., Stuart, Katherine A., Finnigan, Simon, Hinson, Jan, Bernardes, Christina M., Hartel, Gunter and Valery, Patricia C. (2023). Low prevalence of use of allied health and community services for patients with cirrhosis in Australia: a need for greater engagement. Patient Preference and Adherence, Volume 17, 1117-1130. doi: 10.2147/ppa.s405567

Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, Australia

Valery, Patricia C., Stuart, Katherine A., Bernardes, Christina M., Hartel, Gunter, Martin, Cathy, Gordon, Louisa and Powell, Elizabeth E. (2023). Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, Australia. Hepatology Communications, 7 (3) e0066, 1-13. doi: 10.1097/hc9.0000000000000066

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Rinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Journal of Hepatology, 79 (6), 1542-1556. doi: 10.1016/j.jhep.2023.06.003

Serum CCL2 is associated with visceral adiposity but not fibrosis in patients with Non-alcoholic Fatty Liver Disease (NAFLD)

Ferrari-Cestari, Michelle, Okano, Satomi, Patel, Preya J., Horsfall, Leigh U., Keshvari, Sahar, Hume, David A., Williams, Suzanne, Russell, Anthony, Powell, Elizabeth E. and Irvine, Katharine M (2023). Serum CCL2 is associated with visceral adiposity but not fibrosis in patients with Non-alcoholic Fatty Liver Disease (NAFLD). Digestive Diseases, 41 (3), 439-446. doi: 10.1159/000527784

Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes

Gracen, Lucy, Hayward, Kelly L., Aikebuse, Melanie, Russell, Anthony, O’Beirne, James, McPhail, Steven, Irvine, Katharine M., Williams, Suzanne, Valery, Patricia C. and Powell, Elizabeth E. (2022). Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes. BMC Health Services Research, 22 (1) 487, 1-11. doi: 10.1186/s12913-022-07808-7

Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study

Valery, Patricia C., Bernardes, Christina M., Hayward, Kelly L., Hartel, Gunter, Haynes, Katelin, Gordon, Louisa G., Stuart, Katherine A., Wright, Penny L., Johnson, Amy and Powell, Elizabeth E. (2022). Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study. BMC Gastroenterology, 22 (1) 340, 1-11. doi: 10.1186/s12876-022-02407-6

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

Canivet, Clémence M., Costentin, Charlotte, Irvine, Katharina M., Delamarre, Adèle, Lannes, Adrien, Sturm, Nathalie, Oberti, Frederic, Patel, Preya J., Decaens, Thomas, Irles-Depé, Marie, Fouchard, Isabelle, Hermabessière, Paul, Roux, Marine, Barthelon, Justine, Calès, Paul, Powell, Elizabeth E., de Ledinghen, Victor and Boursier, Jérôme (2022). Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD. Hepatology, 77 (3), n/a-n/a. doi: 10.1002/hep.32665

Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis

Gracen, Lucy, Hayward, Kelly L., Irvine, Katharine M., Valery, Patricia C. and Powell, Elizabeth E. (2022). Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis. Journal of Hepatology, 77 (4), 1219-1221. doi: 10.1016/j.jhep.2022.06.016

Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: a population-based study

Ratnasekera, Isanka U., Johnson, Amy, Powell, Elizabeth E., Henderson, Andrew, Irvine, Katharine M. and Valery, Patricia C. (2022). Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: a population-based study. Medicine, 101 (20) 00010, e29217. doi: 10.1097/MD.0000000000029217

Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis

Hayward, Kelly L., Bansal, Vikas, Valery, Patricia C., Irvine, Katharine M., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., Cottrell, W. Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2022). Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis. Hepatology Communications, 6 (11), 3281-3282. doi: 10.1002/hep4.1999

Complexity of ballooned hepatocyte feature recognition: defining a training atlas for artificial intelligence-based imaging in NAFLD

Brunt, Elizabeth M., Clouston, Andrew D., Goodman, Zachary, Guy, Cynthia, Kleiner, David E., Lackner, Carolin, Tiniakos, Dina G., Wee, Aileen, Yeh, Matthew, Leow, Wei Qiang, Chng, Elaine, Ren, Yayun, Boon Bee, George Goh, Powell, Elizabeth E., Rinella, Mary, Sanyal, Arun J., Neuschwander-Tetri, Brent, Younossi, Zobair, Charlton, Michael, Ratziu, Vlad, Harrison, Stephen A., Tai, Dean and Anstee, Quentin M. (2022). Complexity of ballooned hepatocyte feature recognition: defining a training atlas for artificial intelligence-based imaging in NAFLD. Journal of Hepatology, 76 (5), 1030-1041. doi: 10.1016/j.jhep.2022.01.011

Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis

Brown, Catherine, Shahid, Shaouli, Bernardes, Christina M., Toombs, Maree, Clark, Paul J., Powell, Elizabeth E. and Valery, Patricia C. (2022). Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis. Journal of Clinical Nursing, 32 (11-12), 2559-2574. doi: 10.1111/jocn.16302

Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease

Jouffe, Céline, Weger, Benjamin D., Martin, Eva, Atger, Florian, Weger, Meltem, Gobet, Cédric, Ramnath, Divya, Charpagne, Aline, Morin-Rivron, Delphine, Powell, Elizabeth E., Sweet, Matthew J., Masoodi, Mojgan, Uhlenhaut, N. Henriette and Gachon, Frédéric (2022). Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease. Proceedings of the National Academy of Sciences, 119 (10) e2200083119, e2200083119. doi: 10.1073/pnas.2200083119

Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review”

Valery, Patricia Casarolli and Powell, Elizabeth Ellen (2022). Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review”. JHEP Reports, 4 (2) 100393. doi: 10.1016/j.jhepr.2021.100393

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism

Radford-Smith, Daniel E., Patel, Preya J., Irvine, Katharine M., Russell, Anthony, Siskind, Dan, Anthony, Daniel C., Powell, Elizabeth E. and Probert, Fay (2022). Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism. PLoS ONE, 17 (1) e0261555, e0261555. doi: 10.1371/journal.pone.0261555

An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care

Gracen, Lucy, Hayward, Kelly L., Aikebuse, Melanie, Williams, Suzanne, Russell, Anthony, O'Beirne, James, Powell, Elizabeth E. and Valery, Patricia C. (2022). An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care. Diabetic Medicine, 39 (6) e14799, e14799. doi: 10.1111/dme.14799

Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease

Keshvari, Sahar, Genz, Berit, Teakle, Ngari, Caruso, Melanie, Cestari, Michelle F., Patkar, Omkar L., Tse, Brian W. C., Sokolowski, Kamil A., Ebersbach, Hilmar, Jascur, Julia, MacDonald, Kelli P. A., Miller, Gregory, Ramm, Grant A., Pettit, Allison R., Clouston, Andrew D., Powell, Elizabeth E., Hume, David A. and Irvine, Katharine M. (2022). Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease. Disease Models and Mechanisms, 15 (4) dmm049387, 1-15. doi: 10.1242/dmm.049387

Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study

Johnson, Amy L., Ratnasekera, Isanka U., Irvine, Katharine M., Henderson, Andrew, Powell, Elizabeth E. and Valery, Patricia C. (2021). Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study. BMJ Open Gastroenterology, 8 (1) e000695. doi: 10.1136/bmjgast-2021-000695

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease

Irvine, Katharine M., Okano, Satomi, Patel, Preya J., Horsfall, Leigh U., Williams, Suzanne, Russell, Anthony and Powell, Elizabeth E. (2021). Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease. Scientific Reports, 11 (1) 2858, 1-8. doi: 10.1038/s41598-021-82315-z

Medication discrepancies and regimen complexity in decompensated cirrhosis: implications for medication safety

Hayward, Kelly L., Valery, Patricia C., Patel, Preya J., Li, Catherine, Horsfall, Leigh U., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., David, Michael, Irvine, Katharine M., Cottrell, Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2021). Medication discrepancies and regimen complexity in decompensated cirrhosis: implications for medication safety. Pharmaceuticals, 14 (12) 1207. doi: 10.3390/ph14121207

Predicting liver‐related outcomes in people with nonalcoholic fatty liver disease: the prognostic value of noninvasive fibrosis tests

Johnson, Amy L., Hayward, Kelly L., Patel, Preya, Horsfall, Leigh U., Cheah, Alvin Ee Zhiun, Irvine, Katharine M., Russell, Anthony W., Stuart, Katherine A., Williams, Sue, Hartel, Gunter, Valery, Patricia C. and Powell, Elizabeth E. (2021). Predicting liver‐related outcomes in people with nonalcoholic fatty liver disease: the prognostic value of noninvasive fibrosis tests. Hepatology Communications, 6 (4), 728-739. doi: 10.1002/hep4.1852

Towards collaborative management of nonalcoholic fatty liver disease ( TCM‐NAFLD ): a ‘real‐world’ pathway for fibrosis risk assessment in primary care

Hayward, Kelly L., McKillen, Benjamin J., Horsfall, Leigh U., McIvor, Carolyn, Liew, Katerina, Sexton, Jo, Johnson, Amy L., Irvine, Katharine M., Valery, Patricia C., McPhail, Steven M., Britton, Laurence J., Rosenberg, William, Weate, Ingrid, Williams, Sue and Powell, Elizabeth E. (2021). Towards collaborative management of nonalcoholic fatty liver disease ( TCM‐NAFLD ): a ‘real‐world’ pathway for fibrosis risk assessment in primary care. Internal Medicine Journal, 52 (10) imj.15422, 1749-1758. doi: 10.1111/imj.15422

Non-alcoholic fatty liver disease

Powell, Elizabeth E., Wong, Vincent Wai-Sun and Rinella, Mary (2021). Non-alcoholic fatty liver disease. The Lancet, 397 (10290), 2212-2224. doi: 10.1016/S0140-6736(20)32511-3

Remoteness of residence predicts tumor stage, receipt of treatment, and mortality in patients with hepatocellular carcinoma

Taye, Belaynew W., Clark, Paul J., Hartel, Gunter, Powell, Elizabeth E. and Valery, Patricia C. (2021). Remoteness of residence predicts tumor stage, receipt of treatment, and mortality in patients with hepatocellular carcinoma. JGH Open, 5 (7) jgh3.12580, 754-762. doi: 10.1002/jgh3.12580

Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia

Wigg, Alan J., Narayana, Sumudu K., Hartel, Gunter, Medlin, Linda, Pratt, Greg, Powell, Elizabeth E., Clark, Paul, Davies, Jane, Campbell, Kirsty, Toombs, Maree, Larkin, Michael and Valery, Patricia C (2021). Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia. EClinicalMedicine, 36 100919, 1-9. doi: 10.1016/j.eclinm.2021.100919

Non-alcoholic fatty liver disease: raising awareness of a looming public health problem

Gracen, Lucy and Powell, Elizabeth E. (2021). Non-alcoholic fatty liver disease: raising awareness of a looming public health problem. The Medical Journal of Australia, 215 (2) mja2.51109, 75-76. doi: 10.5694/mja2.51109

The patient’s perspective in cirrhosis: unmet supportive care needs differ by disease severity, etiology, and age

Valery, Patricia C., Bernardes, Christina M., Mckillen, Benjamin, Amarasena, Samath, Stuart, Katherine A., Hartel, Gunter, Clark, Paul J., Skoien, Richard, Rahman, Tony, Horsfall, Leigh, Hayward, Kelly, Gupta, Rohit, Lee, Andrew, Pillay, Leshni and Powell, Elizabeth E. (2021). The patient’s perspective in cirrhosis: unmet supportive care needs differ by disease severity, etiology, and age. Hepatology Communications, 5 (5), 891-905. doi: 10.1002/hep4.1681

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM

Hayward, Kelly Lee, Johnson, Amy L., Horsfall, Leigh U., Moser, Chris, Valery, Patricia C. and Powell, Elizabeth E. (2021). Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterology, 8 (1) 000572, e000572. doi: 10.1136/bmjgast-2020-000572

Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis

McPhail, Steven M., Amarasena, Samath, Stuart, Katherine A., Hayward, Kelly, Gupta, Rohit, Brain, David, Hartel, Gunter, Rahman, Tony, Clark, Paul J., Bernardes, Christina M., Skoien, Richard, Mckillen, Benjamin, Lee, Andrew, Pillay, Leshni, Lin, Lei, Khaing, Myat Myat, Horsfall, Leigh, Powell, Elizabeth E. and Valery, Patricia C. (2021). Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis. JGH Open, 5 (1), 133-142. doi: 10.1002/jgh3.12462

Disparities in unmet needs in Indigenous and non-Indigenous Australians with cirrhosis: an exploratory study

Bernardes, Christina M., Clark, Paul J., Brown, Cath, Stuart, Katherine, Pratt, Gregory, Toombs, Maree, Hartel, Gunter, Powell, Elizabeth E. and Valery, Patricia C. (2021). Disparities in unmet needs in Indigenous and non-Indigenous Australians with cirrhosis: an exploratory study. Patient Preference and Adherence, 15, 2649-2658. doi: 10.2147/PPA.S341566

Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis

Hayward, Kelly L., Valery, Patricia C., Patel, Preya J., Horsfall, Leigh U., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., David, Michael, Irvine, Katharine M., Cottrell, W. Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2020). Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis. Internal Medicine Journal, 50 (9), 1142-1146. doi: 10.1111/imj.14986

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies

Hayward, Kelly L., Johnson, Amy L., Mckillen, Benjamin J., Burke, Niall T., Bansal, Vikas, Horsfall, Leigh U., Hartel, Gunter, Moser, Chris, Powell, Elizabeth E. and Valery, Patricia C. (2020). ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterology, 7 (1) e000485, 1-7. doi: 10.1136/bmjgast-2020-000485

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

Adams, Leon A., Roberts, Stuart K., Strasser, Simone I., Mahady, Suzanne E., Powell, Elizabeth, Estes, Chris, Razavi, Homie and George, Jacob (2020). Nonalcoholic fatty liver disease burden: Australia, 2019–2030. Journal of Gastroenterology and Hepatology, 35 (9), 1628-1635. doi: 10.1111/jgh.15009

Longitudinal change in simple scores identifies fibrosis status in people with nonalcoholic fatty liver disease

McKillen, Benjamin J., Powell, Elizabeth E., Horsfall, Leigh U., Clouston, Andrew D., Brown, Nigel N., Elangovan, Harendran, Patel, Preya J., Valery, Patricia C., Irvine, Katharine M., Bernard, Anne and Hayward, Kelly L. (2020). Longitudinal change in simple scores identifies fibrosis status in people with nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology, 54 (7), 661-662. doi: 10.1097/MCG.0000000000001372

Stereotactic radiotherapy for hepatocellular carcinoma: expanding the multidisciplinary armamentarium

Shanker, Mihir D., Liu, Howard Y., Lee, Yoo Young, Stuart, Katherine A., Powell, Elizabeth E., Wigg, Alan and Pryor, David I. (2020). Stereotactic radiotherapy for hepatocellular carcinoma: expanding the multidisciplinary armamentarium. Journal of Gastroenterology and Hepatology, 36 (4) jgh.15175, 873-884. doi: 10.1111/jgh.15175

Type 2 diabetes: a risk factor for hospital readmissions and mortality in Australian patients with cirrhosis

Ahn, Sang Bong, Powell, Elizabeth E., Russell, Anthony, Hartel, Gunter, Irvine, Katharine M., Moser, Chris and Valery, Patricia C. (2020). Type 2 diabetes: a risk factor for hospital readmissions and mortality in Australian patients with cirrhosis. Hepatology Communications, 4 (9) hep4.1536, 1279-1292. doi: 10.1002/hep4.1536

Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)

Brain, David, O'Beirne, James, Hickman, Ingrid J., Powell, Elizabeth E., Valery, Patricia C., Kularatna, Sanjeewa, Tulleners, Ruth, Farrington, Alison, Horsfall, Leigh and Barnett, Adrian (2020). Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). BMC Health Services Research, 20 (1) 335, 335. doi: 10.1186/s12913-020-05233-2

Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)

Valery, Patricia C, Bernardes, Christina M, Stuart, Katherine A, Hartel, Gunter F, McPhail, Steven M, Skoien, Richard, Rahman, Tony, Clark, Paul J, Horsfall, Leigh U, Hayward, Kelly L, Gupta, Rohit and Powell, Elizabeth E (2020). Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient Preference and Adherence, 14, 599-611. doi: 10.2147/ppa.s236818

Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosis

Valery, Patricia C., McPhail, Steven, Stuart, Katherine A., Hartel, Gunter, Clark, Paul J., O'Beirne, James, Skoien, Richard, Rahman, Tony, Moser, Chris and Powell, Elizabeth E. (2020). Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosis. Internal Medicine Journal, 51 (5) imj.14809, 691-698. doi: 10.1111/imj.14809

Nonalcoholic fatty liver disease: interface between primary care and hepatology clinics

Elangovan, Harendran, Rajagopaul, Sashen, Williams, Suzanne M., McKillen, Benjamin, Britton, Laurence, McPhail, Steven M., Horsfall, Leigh U., Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2020). Nonalcoholic fatty liver disease: interface between primary care and hepatology clinics. Hepatology Communications, 4 (4) hep4.1486, 518-526. doi: 10.1002/hep4.1486

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians

Valery, Patricia C., Clark, Paul J., Pratt, Gregory, Bernardes, Christina M., Hartel, Gunter, Toombs, Maree, Irvine, Katharine M. and Powell, Elizabeth E. (2020). Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians. International Journal for Equity in Health, 19 (1) 27, 27. doi: 10.1186/s12939-020-1144-6

Unusual iron and copper studies in a patient with liver injury and normocytic anemia

Ruddell, Richard G., Lee, Andrew, Powell, Elizabeth E., Wilgen, Urs and Ungerer, Jacobus P. J. (2020). Unusual iron and copper studies in a patient with liver injury and normocytic anemia. Clinical Chemistry, 66 (2), 277-281. doi: 10.1093/clinchem/hvz001

Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores

Janubhai Patel, Preya, Chieh-Yu Cheng, Johnson, Banh, Xuan, Gracen, Lucy, Radford-Smith, Daniel, Hossain, Fabrina, Horsfall, Leigh Ula, Lee Hayward, Kelly, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine Anne, Russell, Anthony William, Valery, Patricia Casarolli, Clouston, Andrew Donald, Irvine, Katharine Margaret, Bernard, Anne and Powell, Elizabeth Ellen (2019). Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores. Clinical Gastroenterology and Hepatology, 18 (3), 710-718.e4. doi: 10.1016/j.cgh.2019.07.036

Reply

Hayward, Kelly L., Valery, Patricia C., Cottrell, W. Neil, Irvine, Katharine M., Martin, Jennifer H. and Powell, Elizabeth E. (2019). Reply. Hepatology Communications, 3 (9), 1283-1284. doi: 10.1002/hep4.1398

Contemporary Educational Interventions for General Practitioners (GPs) in Primary Care Settings in Australia: A Systematic Literature Review

Bernardes, Christina Maresch, Ratnasekera, Isanka Umayangani, Kwon, Joo Hyun, Somasundaram, Sivagowri, Mitchell, Geoff, Shahid, Shaouli, Meiklejohn, Judith, Beirne, James O., Valery, Patricia Casarolli and Powell, Elizabeth (2019). Contemporary Educational Interventions for General Practitioners (GPs) in Primary Care Settings in Australia: A Systematic Literature Review. Frontiers in Public Health, 7 (JUN) 176, 176. doi: 10.3389/fpubh.2019.00176

Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation

Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Gupta, Praveer K., Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J., Fairlie, David P. and Iyer, Abishek (2019). Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation. British Journal of Pharmacology, 176 (19) bph.14768, 3775-3790. doi: 10.1111/bph.14768

Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis

Yang, Yoon Mee, Noureddin, Mazen, Liu, Cheng, Ohashi, Koichiro, Kim, So Yeon, Ramnath, Divya, Powell, Elizabeth E., Sweet, Matthew J., Roh, Yoon Seok, Hsin, I-Fang, Deng, Nan, Liu, Zhenqiu, Liang, Jiurong, Mena, Edward, Shouhed, Daniel, Schwabe, Robert F., Jiang, Dianhua, Lu, Shelly C., Noble, Paul W. and Seki, Ekihiro (2019). Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Science Translational Medicine, 11 (496) eaat9284, eaat9284. doi: 10.1126/scitranslmed.aat9284

Engaging primary care clinicians in the assessment of NAFLD

Valery, Patricia C. and Powell, Elizabeth E. (2019). Engaging primary care clinicians in the assessment of NAFLD. Nature Reviews Gastroenterology and Hepatology, 16 (8), 458-460. doi: 10.1038/s41575-019-0164-4

Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians

Powell, Elizabeth E., Skoien, Richard, Rahman, Tony, Clark, Paul J., O'Beirne, James, Hartel, Gunter, Stuart, Katherine A., McPhail, Steven M., Gupta, Rohit, Boyd, Peter and Valery, Patricia C. (2019). Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians. EClinicalMedicine, 11, 44-53. doi: 10.1016/j.eclinm.2019.05.007

Medication‐related problems in outpatients with decompensated cirrhosis: Opportunities for harm prevention

Hayward, Kelly L., Patel, Preya J., Valery, Patricia C., Horsfall, Leigh U., Li, Catherine Y., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., Irvine, Katharine M., Cottrell, W. Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2019). Medication‐related problems in outpatients with decompensated cirrhosis: Opportunities for harm prevention. Hepatology Communications, 3 (5) hep4.1334, 620-631. doi: 10.1002/hep4.1334

Causes and consequences of innate immune dysfunction in cirrhosis

Irvine, Katharine Margaret, Ratnasekera, Isanka, Powell, Elizabeth E. and Hume, David Arthur (2019). Causes and consequences of innate immune dysfunction in cirrhosis. Frontiers in Immunology, 10 (FEB) 293, 293. doi: 10.3389/fimmu.2019.00293

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

Sharkawy, Rasha El, Bayoumi, Ali, Metwally, Mayada, Mangia, Alessandra, Berg, Thomas, Romero-Gomez, Manuel, Abate, Maria Lorena, Irving, William L., Sheridan, David, Dore, Gregory J., Spengler, Ulrich, Lampertico, Pietro, Bugianesi, Elisabetta, Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Santoro, Rosanna, Gallego-Durán, Rocío, Fischer, Janett, Nattermann, Jacob, D’Ambrosio, Roberta, McLeod, Duncan, Powell, Elizabeth, latchoumanin, Olivier, Thabet, Khaled, Najim, Mustafa A. M., Douglas, Mark W., Liddle, Christopher ... Jonsson, Julie R. (2019). A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Scientific Reports, 9 (1) 1439, 1439. doi: 10.1038/s41598-018-35736-2

Corrigendum: Causes and consequences of innate immune dysfunction in cirrhosis (Frontiers in Immunology (2019) 10 (293) DOI: 10.3389/fimmu.2019.00293)

Irvine, Katharine Margaret, Ratnasekera, Isanka, Powell, Elizabeth E. and Hume, David Arthur (2019). Corrigendum: Causes and consequences of innate immune dysfunction in cirrhosis (Frontiers in Immunology (2019) 10 (293) DOI: 10.3389/fimmu.2019.00293). Frontiers in Immunology, 10 (APR) 818, 818. doi: 10.3389/fimmu.2019.00818

A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care

Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Bernard, Anne, Brown, Nigel Neil, Lampe, Guy, Buck, Lyndall, Saad, Nivene, Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Rosenberg, William and Powell, Elizabeth Ellen (2018). A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatology Communications, 2 (8), 893-905. doi: 10.1002/hep4.1208

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath, Divya, Irvine, Katharine M., Lukowski, Samuel W., Horsfall, Leigh U., Loh, Zhixuan, Clouston, Andrew D., Patel, Preya J., Fagan, Kevin J., Iyer, Abishek, Lampe, Guy, Stow, Jennifer L., Schroder, Kate, Fairlie, David P., Powell, Joseph E., Powell, Elizabeth E. and Sweet, Matthew J. (2018). Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight, 3 (14). doi: 10.1172/jci.insight.120274

Weight based tacrolimus trough concentrations post liver transplant

Liu, Zheng, Cheng, Jeffrey, Powell, Elizabeth, Macdonald, Graeme, Fawcett, Jonathan, Lynch, Stephen and Martin, Jennifer (2018). Weight based tacrolimus trough concentrations post liver transplant. Internal Medicine Journal, 49 (1), 79-83. doi: 10.1111/imj.14043

Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control

Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Russell, Anthony William and Powell, Elizabeth Ellen (2018). Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications, 32 (8), 799-804. doi: 10.1016/j.jdiacomp.2018.05.008

Haemochromatosis: a clinical update for the practising physician

Radford-Smith, Daniel E., Powell, Elizabeth E. and Powell, Lawrie W. (2018). Haemochromatosis: a clinical update for the practising physician. Internal Medicine Journal, 48 (5), 509-516. doi: 10.1111/imj.13784

Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis

Patel, Preya J., Banh, Xuan, Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew, Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C., Williams, Suzanne and Powell, Elizabeth E (2018). Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Medicine Journal, 48 (2), 144-151. doi: 10.1111/imj.13667

Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis

Maradana, Muralidhara Rao, Yekollu, Suman Kumar, Zeng, Bijun, Ellis, Jonathan, Clouston, Andrew, Miller, Gregory, Talekar, Meghna, Bhuyan, Zaied Ahmed, Mahadevaiah, Sachin, Powell, Elizabeth E., Irvine, Katharine M., Thomas, Ranjeny and O'Sullivan, Brendan John (2018). Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism: Clinical and Experimental, 78, 80-94. doi: 10.1016/j.metabol.2017.09.002

Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease

Patel, Preya J., Smith, David, Connor, Jason P., Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew D., Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C. and Powell, Elizabeth E. (2017). Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease. Canadian Journal of Gastroenterology and Hepatology, 2017 7927685, 7927685-8. doi: 10.1155/2017/7927685

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

Hayward, Kelly L., Valery, Patricia C., Martin, Jennifer H., Karmakar, Antara, Patel, Preya J., Horsfall, Leigh U., Tallis, Caroline J., Stuart, Katherine A., Wright, Penny L., Smith, David D., Irvine, Katharine M., Powell, Elizabeth E. and Cottrell, W. Neil (2017). Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World Journal of Gastroenterology, 23 (40), 7321-7331. doi: 10.3748/wjg.v23.i40.7321

Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management

Hayward, Kelly L., Horsfall, Leigh U., Ruffin, Brittany J., Cottrell, W. Neil, Chachay, Veronique S., Irvine, Katharine M., Martin, Jennifer H., Powell, Elizabeth E. and Valery, Patricia C. (2017). Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management. Internal Medicine Journal, 47 (8), 952-955. doi: 10.1111/imj.13505

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial

Hayward, Kelly L., Martin, Jennifer H., Cottrell, W. Neil, Karmakar, Antara, Horsfall, Leigh U., Patel, Preya J., Smith, David D., Irvine, Katharine M., Powell, Elizabeth E. and Valery, Patricia C. (2017). Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial. Trials, 18 (1) 339, 339. doi: 10.1186/s13063-017-2075-4

Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management

Patel, Preya Janubhai, Hayward, Kelly Lee, Rudra, Rathiga, Horsfall, Leigh Ula, Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Clouston, Andrew Donald, Stuart, Katherine Anne, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Russell, Anthony William and Powell, Elizabeth Ellen (2017). Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management. Medicine, 96 (26) e6761, e6761. doi: 10.1097/MD.0000000000006761

Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

Valery, Patricia C., Clark, Paul J., McPhail, Steven M., Rahman, Tony, Hayward, Kelly, Martin, Jennifer, Horsfall, Leigh, Volk, Michael L., Skoien, Richard and Powell, Elizabeth (2017). Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. Internal Medicine Journal, 47 (4), 429-435. doi: 10.1111/imj.13380

Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study

Nicoletti, Paola, Aithal, Guruprasad P., Bjornsson, Einar S., Andrade, Raul J. A, Sawle, Ashley, Arrese, Marco, Barnhart, Huiman X., Bondon-Guitton, Emmanuelle, Hayashi, Paul H., Bessone, Fernando, Carvajal, Alfonso, Cascorbi, Ingolf, Cirulli, Elizabeth T., Chalasani, Naga, Conforti, Anita, Coulthard, Sally A., Daly, Mark J., Day, Christopher P., Dillon, John F., Fontana, Robert J., Grove, Jane I., Hallberg, Pär, Hernandez, Nelia, Ibanez, Luisa, Kullak-Ublick, Gerd A., Laitinen, Tarja, Larrey, Dominique, Lucena, M. Isabel, Maitland-van der Zee, Anke H. ... Daly, Ann K. (2017). Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study. Gastroenterology, 152 (5), 1078-1089. doi: 10.1053/j.gastro.2016.12.016

IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis

Eslam, Mohammed, McLeod, Duncan, Kelaeng, Kebitsaone Simon, Mangia, Alessandra, Berg, Thomas, Thabet, Khaled, Irving, William L., Dore, Gregory J., Sheridan, David, Gronbaek, Henning, Abate, Maria Lorena, Hartmann, Rune, Bugianesi, Elisabetta, Spengler, Ulrich, Rojas, Angela, Booth, David R., Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Mahajan, Hema, Fischer, Janett, Nattermann, Jacob, Douglas, Mark W., Liddle, Christopher, Powell, Elizabeth, Romero-Gomez, Manuel and George, Jacob (2017). IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis. Nature Genetics, 49 (5), 795-800. doi: 10.1038/ng.3836

Identifying areas of need relative to liver disease: geographic clustering within a health service district

El-Atem, Nathan, Irvine, Katharine M., Valery, Patricia C., Wojcik, Kyle, Horsfall, Leigh, Johnson, Tracey, Janda, Monika, McPhail, Steven M. and Powell, Elizabeth E. (2017). Identifying areas of need relative to liver disease: geographic clustering within a health service district. Australian Health Review, 41 (4), 407-418. doi: 10.1071/AH15225

Multiplex serum protein analysis identifies novel biomarkers of advanced fibrosis in patients with chronic liver disease with the potential to improve diagnostic accuracy of established biomarkers

Irvine, Katharine M., Wockner, Leesa F., Hoffmann, Isabel, Horsfall, Leigh U., Fagan, Kevin J., Bijin, Veonice, Lee, Bernett, Clouston, Andrew D., Lampe, Guy, Connolly, John E. and Powell, Elizabeth E. (2016). Multiplex serum protein analysis identifies novel biomarkers of advanced fibrosis in patients with chronic liver disease with the potential to improve diagnostic accuracy of established biomarkers. PLoS ONE, 11 (11) 167001, e0167001. doi: 10.1371/journal.pone.0167001

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Thabet, Khaled, Asimakopoulos, Anastasia, Shojaei, Maryam, Romero-Gomez, Manuel, Mangia, Alessandra, Irving, William L., Berg, Thomas, Dore, Gregory J., Gronbaek, Henning, Sheridan, David, Abate, Maria Lorena, Bugianesi, Elisabetta, Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Fischer, Janett, Spengler, Ulrich, Nattermann, Jacob, Wahid, Ahmed, Rojas, Angela, White, Rose, Douglas, Mark W., McLeod, Duncan, Powell, Elizabeth, Liddle, Christopher, Van Der Poorten, David, George, Jacob, Eslam, Mohammed ... Santaro, Rosanna (2016). MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. Nature Communications, 7 (1) 12757, 12757. doi: 10.1038/ncomms12757

Prevalence of medication discrepancies in patients with cirrhosis: A pilot study

Hayward, Kelly L., Valery, Patricia C., Cottrell, W. Neil, Irvine, Katharine M., Horsfall, Leigh U., Tallis, Caroline J., Chachay, Veronique S., Ruffin, Brittany J., Martin, Jennifer H. and Powell, Elizabeth E. (2016). Prevalence of medication discrepancies in patients with cirrhosis: A pilot study. BMC Gastroenterology, 16 (1) 114, 114. doi: 10.1186/s12876-016-0530-4

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

Eslam, Mohammed, Mangia, Alessandra, Berg, Thomas, Chan, Henry Lik Yuen, Irving, William L., Dore, Gregory J., Abate, Maria Lorena, Bugianesi, Elisabetta, Adams, Leon A., Najim, Mustafa A. M., Miele, Luca, Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Fischer, Janett, Romero-Gomez, Manuel, Spengler, Ulrich, Nattermann, Jacob, Rahme, Antony, Sheridan, David, Booth, David R., Mcleod, Duncan, Powell, Elizabeth, Liddle, Christopher, Douglas, Mark W., van der Poorten, Dvaid and George, Jacob (2016). Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Hepatology, 64 (1), 34-46. doi: 10.1002/hep.28475

Altered peripheral blood monocyte phenotype and function in chronic liver disease: implications for hepatic recruitment and systemic inflammation

Gadd, Victoria L., Patel, Preya J., Jose, Sara, Horsfall, Leigh, Powell, Elizabeth E. and Irvine, Katharine M. (2016). Altered peripheral blood monocyte phenotype and function in chronic liver disease: implications for hepatic recruitment and systemic inflammation. PLoS One, 11 (6) e0157771, e0157771. doi: 10.1371/journal.pone.0157771

CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites

Irvine, Katharine M., Xuan Banh, Gadd, Victoria L., Wojcik, Kyle K., Ariffin, Juliana K., Jose, Sara, Lukowski, Samuel, Baillie, Gregory J., Sweet, Matthew J. and Powell, Elizabeth E. (2016). CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites. JCI Insight, 1 (8) e86914, e86914. doi: 10.1172/jci.insight.86914

Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability

von Wulffen, M., Clark, P. J., Macdonald, G. A., Raj, A. S., Kendall, B. J., Powell, E. E., Jones, M. P. and Holtmann, G. (2016). Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability. Alimentary Pharmacology and Therapeutics, 44 (1), 68-77. doi: 10.1111/apt.13657

Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease

El-Atem, N. A., Wojcik, K., Horsfall, L., Irvine, K. M., Johnson, T., McPhail, S. M. and Powell, E. E. (2016). Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease. Internal Medicine Journal, 46 (4), 420-426. doi: 10.1111/imj.13008

Spatiotemporal characterization of the cellular and molecular contributors to liver fibrosis in a murine hepatotoxic-injury model

Melino, Michelle, Gadd, Victoria L., Alexander, Kylie A., Beattie, Lynette, Lineburg, Katie E., Martinez, Michelle, Teal, Bianca, Le Texier, Laetitia, Irvine, Katharine M., Miller, Gregory C., Boyle, Glen M., Hill, Geoffrey R., Clouston, Andrew D., Powel, Elizabeth E. and MacDonald, Kelli P. A. (2016). Spatiotemporal characterization of the cellular and molecular contributors to liver fibrosis in a murine hepatotoxic-injury model. American Journal of Pathology, 186 (3), 524-538. doi: 10.1016/j.ajpath.2015.10.029

The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair

Ramnath, Divya, Powell, Elizabeth E., Scholz, Glen M. and Sweet, Matthew J. (2016). The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair. Seminars in Cell and Developmental Biology, 61, 22-30. doi: 10.1016/j.semcdb.2016.08.014

Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Hayward, Kelly L., Powell, Elizabeth E., Irvine, Katharine M. and Martin, Jennifer H. (2015). Can paracetamol (acetaminophen) be administered to patients with liver impairment?. British Journal of Clinical Pharmacology, 81 (2), 210-222. doi: 10.1111/bcp.12802

FibroGENE: A gene-based model for staging liver fibrosis

Eslam, Mohammed, Hashem, Ahmed M., Romero-Gomez, Manuel, Berg, Thomas, Dore, Gregory J., Mangia, Alessandra, Chan, Henry Lik Yuen, Irving, William L., Sheridan, David, Abate, Maria Lorena, Adams, Leon A., Weltman, Martin, Bugianesi, Elisabetta, Spengler, Ulrich, Shaker, Olfat, Fischer, Janett, Mollison, Lindsay, Cheng, Wendy, Nattermann, Jacob, Riordan, Stephen, Miele, Luca, Kelaeng, Kebitsaone Simon, Ampuero, Jacob, Ahlenstiel, Golo, McLeod, Duncan, Powell, Elizabeth, Liddle, Christopher, Douglas, Mark W., Booth, David R. and George, Jacob (2015). FibroGENE: A gene-based model for staging liver fibrosis. Journal of Hepatology, 64 (2), 390-398. doi: 10.1016/j.jhep.2015.11.008

Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury

Irvine, Katharine M., Clouston, Andrew D., Gadd, Victoria L., Miller, Gregory C., Wong, Weng-Yew, Melino, Michelle, Maradana, Muralidhara Rao, MacDonald, Kelli, Lang, Richard A., Sweet, Matthew J., Blumenthal, Antje and Powell, Elizabeth E. (2015). Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury. Fibrogenesis and Tissue Repair, 8 (19) 19, 19. doi: 10.1186/s13069-015-0036-7

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

Irvine, Katharine M., Wockner, Leesa F., Shanker, Mihir, Fagan, Kevin J., Horsfall, Leigh U., Fletcher, Linda M., Ungerer, Jacobus P. J., Pretorius, Carel J., Miller, Gregory C., Clouston, Andrew D., Lampe, Guy and Powell, Elizabeth E. (2015). The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease. Liver International, 36 (3), 370-377. doi: 10.1111/liv.12896

Response to ELF cut-off points: aetiology is also a relevant factor

Powell, Elizabeth E., Irvine, Katharine M., Fagan, Kevin J., Ballard, Emma and O'Rourke, Peter (2015). Response to ELF cut-off points: aetiology is also a relevant factor. Liver International, 35 (7), 1921-1921. doi: 10.1111/liv.12822

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

Fagan, Kevin J., Pretorius, Carel J., Horsfall, Leigh U., Irvine, Katharine M., Wilgen, Urs, Choi, Kihoon, Fletcher, Linda M., Tate, Jill, Melino, Michelle, Nusrat, Sharmin, Miller, Gregory C., Clouston, Andrew D., Ballard, Emma, O'Rourke, Peter, Lampe, Guy, Ungerer, Jacobus P. J. and Powell, Elizabeth E. (2015). ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. Liver International, 35 (6), 1673-1681. doi: 10.1111/liv.12760

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease

Valery, Patricia C., Powell, Elizabeth, Moses, Neta, Volk, Michael L., McPhail, Steven M., Clark, Paul J. and Martin, Jennifer (2015). Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease. BMJ Open, 5 (4) e007451, 1-16. doi: 10.1136/bmjopen-2014-007451

Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection

Fagan, Kevin J., Rogers, Geraint B., Melino, Michelle, Arthur, Dionne M., Costello, Mary-Ellen, Morrison, Mark, Powell, Elizabeth E. and Irvine, Katharine M. (2015). Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection. PLoS One, 10 (3) e0120642, e0120642. doi: 10.1371/journal.pone.0120642

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease

Eslam, Mohammed, Hashem, Ahmed M, Leung, Reynold, Romero-Gomez, Manuel, Berg, Thomas, Dore, Gregory J, Chan, Henry L.K, Irving, William L, Sheridan, David, Abate, Maria L, Adams, Leon A, Mangia, Alessandra, Weltman, Martin, Bugianesi, Elisabetta, Spengler, Ulrich, Shaker, Olfat, Fischer, Janett, Mollison, Lindsay, Cheng, Wendy, Powell, Elizabeth, Nattermann, Jacob, Riordan, Stephen, McLeod, Duncan, Armstrong, Nicola J, Douglas, Mark W, Liddle, Christopher, Booth, David R, George, Jacob, Ahlenstiel, Golo ... Santaro, Rosanna (2015). Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nature Communications, 6 (6422) 6422. doi: 10.1038/ncomms7422

Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration

Irvine, Katharine M., Skoien, Richard, Bokil, Nilesh J., Melino, Michelle, Thomas, Gethin P., Loo, Dorothy, Gabrielli, Brian, Hill, Michelle M., Sweet, Matthew J., Clouston, Andrew D. and Powell, Elizabeth E. (2014). Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. World Journal of Gastroenterology, 20 (47), 17851-17862. doi: 10.3748/wjg.v20.i47.17851

Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change?

Fagan, K. J., Zhao, Eileen Y., Horsfall, L. U., Ruffin, Brittany J., Kruger, Mark S., McPhail, S. M., O'Rourke, Peter, Ballard, Emma, Irvine, K. M. and Powell, E. E. (2014). Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change?. Internal Medicine Journal, 44 (9), 865-872. doi: 10.1111/imj.12491

Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers

Fagan K.J., Irvine K.M., McWhinney B.C., Fletcher L.M., Horsfall L.U., Johnson L., O'Rourke P., Martin J., Scott I., Pretorius C.J., Ungerer J.P.J. and Powell E.E. (2014). Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers. BMC Gastroenterology, 14 (1) 97, 1-6. doi: 10.1186/1471-230X-14-97

The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

Gadd, Victoria L., Skoien, Richard, Powell, Elizabeth E., Fagan, Kevin J., Winterford, Clay, Horsfall, Leigh, Irvine, Katharine and Clouston, Andrew D. (2014). The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology, 59 (4), 1393-1405. doi: 10.1002/hep.26937

New paradigms in the histopathology of NAFLD

Clouston, Andrew D., Gadd, Victoria L., Irvine, Katharine M. and Powell, Elizabeth E. (2014). New paradigms in the histopathology of NAFLD. Current Hepatitis Reports, 13 (2), 81-87. doi: 10.1007/s11901-014-0214-x

Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention

Fagan, K. J., Irvine, K. M., Kumar, S., Bates, A., Horsfall, L. U., Feeney, G. F. and Powell, E. E. (2013). Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention. Internal Medicine Journal, 43 (10), 1096-1102. doi: 10.1111/imj.12229

BMI But Not Stage or Etiology of Nonalcoholic Liver Disease Affects the Diagnostic Utility of Carbohydrate-Deficient Transferrin

Fagan, Kevin J., Irvine, Katharine M., McWhinney, Brett C., Fletcher, Linda M., Horsfall, Leigh U., Johnson, Lambro A., Clouston, Andrew D., Jonsson, Julie R., O'Rourke, Peter, Martin, Jennifer, Pretorius, Carel J., Ungerer, Jacobus P. J. and Powell, Elizabeth E. (2013). BMI But Not Stage or Etiology of Nonalcoholic Liver Disease Affects the Diagnostic Utility of Carbohydrate-Deficient Transferrin. Alcoholism Clinical and Experimental Research, 37 (10), 1771-1778. doi: 10.1111/acer.12143

Khat-associated hepatitis

Forbes, Malcolm P., Raj, Ashok S., Martin, Jennifer, Lampe, Guy and Powell, Elizabeth E. (2013). Khat-associated hepatitis. Medical Journal of Australia, 199 (7), 498-499. doi: 10.5694/mja13.10951

CCR5-Delta 32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

Suppiah, V., Armstrong, N. J., O'Connor, K. S., Berg, T., Weltman, M., Abate, M. L., Spengler, U., Bassendine, M., Dore, G. J., Irving, W. L., Powell, E., Nattermann, J., Mueller, T., Riordan, S., Stewart, G. J., George, J., Booth, D. R., Ahlenstiel, G., The International Hepatitis C Genetics Consortium (IHCGC), Jonsson, Julie R. and Barrie, Helen (2013). CCR5-Delta 32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes and Immunity, 14 (5), 286-290. doi: 10.1038/gene.2013.15

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

Skoien, Richard, Richardson, Michelle M., Jonsson, Julie R., Powell, Elizabeth E., Brunt, Elizabeth M., Neuschwander-Tetri, Brent A., Bhathal, Prithi S., Dixon, John B., O'Brien, Paul E., Tilg, Herbert, Moschen, Alexander R., Baumann, Ulrich, Brown, Rachel M., Couper, Richard T., Manton, Nicholas D., Ee, Looi C., Weltman, Martin and Clouston, Andrew D. (2013). Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver International, 33 (4), 624-632. doi: 10.1111/liv.12100

Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C

Gadd, Victoria L., Melino, Michelle, Roy, Sandrine, Horsfall, Leigh, O'Rourke, Peter, Williams, Millicent R., Irvine, Katharine M., Sweet, Matthew J., Jonsson, Julie R., Clouston, Andrew D. and Powell, Elizabeth E. (2013). Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C. Liver International, 33 (4), 569-579. doi: 10.1111/liv.12050

Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists

Bergqvist, C. -J., Skoien, R., Horsfall, L., Clouston, A. D., Jonsson, J. R. and Powell, E. E. (2013). Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists. Internal Medicine Journal, 43 (3), 247-253. doi: 10.1111/j.1445-5994.2012.02848.x

Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C

Horsfall, Leigh, Macdonald, Graeme, Scott, Ian, Skoien, Richard, Khatun, Mohsina, Moss, Cathy, Seligman, Clare, Kardash, Christine, Poxon, Vicki and Powell, Elizabeth E. (2013). Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C. Australian Health Review, 37 (2), 218-222. doi: 10.1071/AH12162

Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

Patin, Etienne, Kutalik, Zoltan, Guergnon, Julien, Bibert, Stephanie, Nalpas, Bertrand, Jouanguy, Emmanuelle, Munteanu, Mona, Bousquet, Laurence, Argiro, Laurent, Halfon, Philippe, Boland, Anne, Muellhaupt, Beat, Semela, David, Dufour, Jean-Francois, Heim, Markus H., Moradpour, Darius, Cerny, Andreas, Malinverni, Raffaele, Hirsch, Hans, Martinetti, Gladys, Suppiah, Vijayaprakash, Stewart, Graeme, Booth, David R., George, Jacob, Casanova, Jean-Laurent, Brechot, Christian, Rice, Charles M., Talal, Andrew H., Jacobson, Ira M. ... French ANRS HC EP 26 Genoscan Study Group (2012). Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection. Gastroenterology, 143 (5), 1244-+. doi: 10.1053/j.gastro.2012.07.097

Liver repercussions of defective gut surveillance

Irvine, Katharine M., Schroder, Elizabeth E. and Powell, Elizabeth E. (2012). Liver repercussions of defective gut surveillance. Hepatology, 56 (3), 1174-1177. doi: 10.1002/hep.25944

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

Melino, Michelle, Gadd, Victoria L., Walker, Gene V., Skoien, Richard, Barrie, Helen D., Jothimani, Dinesh, Horsfall, Leigh, Jones, Alun, Sweet, Matthew J., Thomas, Gethin P., Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2012). Macrophage secretory products induce an inflammatory phenotype in hepatocytes. World Journal of Gastroenterology, 18 (15), 1732-1744. doi: 10.3748/wjg.v18.i15.1732

Triage of referrals to outpatient hepatology services: an ineffective tool to prioritise patients?

Horsfall, Leigh, Skoien, Richard, Moss, Cathy, Scott, Ian, Macdonald, Graeme A. and Powell, Elizabeth E. (2012). Triage of referrals to outpatient hepatology services: an ineffective tool to prioritise patients?. Australian Health Review, 36 (4), 443-447. doi: 10.1071/AH11111

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study

Suppiah, Vijayaprakash, Gaudieri, Silvana, Armstrong, Nicola J., O'Connor, Kate S., Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Dore, Gregory J., Irving, William L., Powell, Elizabeth, Hellard, Margaret, Riordan, Stephen, Matthews, Gail, Sheridan, David, Nattermann, Jacob, Smedile, Antonina, Muller, Tobias, Hammond, Emma, Dunn, David, Negro, Francesco, Bochud, Pierre-Yves, Mallal, Simon, Ahlenstiel, Golo, Stewart, Graeme J., George, Jacob, Booth, David R. and for the International Hepatitis C Genetics Consortium (IHCGC) (2011). IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study. PLoS Medicine, 8 (9) e1001092, e1001092.1-e1001092.8. doi: 10.1371/journal.pmed.1001092

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

Smith, Katherine R., Suppiah, Vijayaprakash, O'Connor, Kate, Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Matthews, Gail, Irving, William L., Powell, Elizabeth, Riordan, Stephen, Ahlenstiel, Golo, Stewart, Graeme J., Bahlo, Melanie, George, Jacob and Booth, David R. (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3 (8) 57. doi: 10.1186/gm273

Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

Moschen, Alexander R., Fritz, Teresa Fritz, Clouston, Andrew D., Rebhan, Ilka, Bauhofer, Oliver, Barrie, Helen D., Powell, Elizabeth E., Kim, Soo-Hyun, Dinarello, Charles A., Bartenschlager, Ralf, Jonsson, Julie R. and Tilg, Herbert (2011). Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology, 53 (6), 1819-1829. doi: 10.1002/hep.24285

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection

McPherson, Stuart, Powell, Elizabeth E., Barrie, Helen D., Clouston, Andrew D., McGuckin, Michael and Jonsson, Julie R. (2011). No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatalogy, 26 (2), 319-327. doi: 10.1111/j.1440-1746.2010.06368.x

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism

Barclay, JL, Nelson, CN, Ishikawa, M, Murray, LA, Kerr, LM, McPhee, TR, Powell, EE and Waters, MJ (2011). GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology, 152 (1), 181-192. doi: 10.1210/en.2010-0537

Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?

Powell, Elizabeth E., Jonsson, Julie R. and Clouston, Andrew D. (2011). Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?. Gut, 60 (1), 1-2. doi: 10.1136/gut.2010.226365

Combined approach for non-invasive measurement of liver pathology by MR

Cowin, Gary J., Jonsson, Julie R., McPherson, Stuart, Clouston, Andrew D., Benson, Mark, Powell, Elizabeth E. and Galloway, Graham J. (2009). Combined approach for non-invasive measurement of liver pathology by MR. Journal of Hepatology, 51 (6), 1083-1084. doi: 10.1016/j.jhep.2009.09.005

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Suppiah, Vijayaprakash, Moldovan, Max, Ahlenstiel, Golo, Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Bassendine, Margaret, Spengler, Ulrich, Dore, Gregory J., Powell, Elizabeth, Riordan, Stephen, Sheridan, David, Smedile, Antonnia, Fragomeli, Vincenzo, Muller, Tobias, Bahlo, Melanie, Stewart, Graeme J., Booth, David R., George, Jacob and Hepatitis C Study (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics, 41 (10), 1100-1104. doi: 10.1038/ng.447

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

McPherson, S., Jonsson, J. R., Cowin, GJ, O'Rourke, P., Clouston, A. D., Volp, A., Horsfall, L., Jothimani, D., Fawcett, J., Galloway, G. J., Benson, M. and Powell, E. E. (2009). Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. Journal of Hepatology, 51 (2), 389-397. doi: 10.1016/j.jhep.2009.04.012

Kupffer cells and hepatocyte metabolism: A two-way street?

Powell, Elizabeth E., Waters, Michael J. and Jonsson, Julie R. (2009). Kupffer cells and hepatocyte metabolism: A two-way street?. Hepatology, 49 (2), 690-692. doi: 10.1002/hep.22801

Hepatic progenitor cell–mediated regeneration and fibrosis: chicken or egg?

Clouston, A. D., Jonsson, J. R. and Powell, E. E. (2009). Hepatic progenitor cell–mediated regeneration and fibrosis: chicken or egg?. Hepatology, 49 (5), 1424-1426. doi: 10.1002/hep.22893

Recognition of genetic factors influencing the progression of Hepatitis C

Jonsson, Julie R., Purdie, David M., Clouston, Andrew D. and Powell, Elizabeth E. (2008). Recognition of genetic factors influencing the progression of Hepatitis C. Molecular Diagnosis and Therapy, 12 (4), 209-218. doi: 10.2165/1250444-200812040-00002

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

McPherson, S., Jonsson, J. R., Barrie, H. D., O'Rourke, P., Clouston, A. D. and Powell, E. (2008). Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. Journal of Hepatology, 49 (6), 1046-1054. doi: 10.1016/j.jhep.2008.06.022

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

Cowin, Gary J., Jonsson, Julie R., Bauer, Judith D., Ash, Susan, Ali, Azmat, Osland, Emma J., Purdie, David M., Clouston, Andrew D., Powell, Elizabeth E. and Galloway, Graham J. (2008). Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. Journal of Magnetic Resonance Imaging, 28 (4), 937-945. doi: 10.1002/jmri.21542

Obesity and steatosis influence serum and hepatic inflammatory in chronic Hepatitis C

Jonsson, J. R., Barrie, H. D., O'Rourke, P., Clouston, A. D. and Powell, E. E. (2008). Obesity and steatosis influence serum and hepatic inflammatory in chronic Hepatitis C. Hepatology, 48 (1), 80-87. doi: 10.1002/hep.22311

Obesity management in liver clinics: Translation of research into clinical practice

Osland, Emma J., Powell, Elizabeth E., Banks, Merrilyn, Jonsson, Julie R. and Hickman, Ingrid J. (2007). Obesity management in liver clinics: Translation of research into clinical practice. Journal of Gastroenterology And Hepatology, 22 (4), 504-509. doi: 10.1111/j.1440-1746.2006.04830.x

Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others

Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2007). Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clinics in Liver Disease, 11 (1), 173-189. doi: 10.1016/j.cld.2007.02.007

An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosis

McPhersonS, Jonsson, JR, BarrieHD, CloustonAD and PowellEE (2007). An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosis. Hepatology, 46 (4), 438A-438A.

An assessment of the role of endoplasmic reticulum (ER) stress in the pathogenesis of HCV

McPhersonS, PowellEE, BarrieHD, CloustonAD and Jonsson, JR (2007). An assessment of the role of endoplasmic reticulum (ER) stress in the pathogenesis of HCV. Hepatology, 46 (4), 444A-444A.

Progressive fibrosis in non-alcoholic steatohepatitis - Association with altered regeneration and a ductular reaction

RichardsonMM, Jonsson, JR, PowellEE, BruntEM, Neuschwander-TetriBA, BhathalPS, DixonJB, WeltmanMD, TilgH, MoschenAR, PurdieDM, DemetrisAJ and CloustonAD (2007). Progressive fibrosis in non-alcoholic steatohepatitis - Association with altered regeneration and a ductular reaction. Journal of Hepatology, 46, S49-S50. doi: 10.1016/S0168-8278(07)61711-5

Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reaction

Richardson M. M., Jonsson, J. R., Powell, E. E., Brunt, EM, Neuschwander-Tetri, BA, Bhathal, PS, Dixon, JB, Weltman, MD, Tilg, H, Moschen, AR, Purdie, DM, Demetris, AJ and Clouston, A. D. (2007). Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reaction. Gastroenterology, 133 (1), 80-90. doi: 10.1053/j.gastro.2007.05.012

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

Walsh, MJ, Jonsson, JR, Richardson, MM, Lipka, GM, Purdie, DM, Clouston, D and Powell, EE (2006). Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut, 55 (4), 529-535. doi: 10.1136/gut.2005.069674

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data

Leandro, G, Mangia, A, Hui, J, Fabris, P, Rubbia-Brandt, L, Colloredo, G, Adinolfi, LE, Asselah, T, Jonsson, JR, Smedile, A, Terrault, N, Pazienza, V, Giordani, MT, Giostra, E, Sonzogni, A, Ruggiero, G, Marcellin, P, Powell, EE, George, J and Negro, F (2006). Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data. Gastroenterology, 130 (6), 1636-1642. doi: 10.1053/j.gastro.2006.03.014

Steatosis is a cofactor in liver injury in hemochromatosis

Powell, Elizabeth E., Ali, Azmat, Clouston, Andrew D., Dixon, Jeannette L., Lincoln, Douglas J., Purdie, David M., Fletcher, Linda M., Powell, Lawrie W. and Jonsson, Julie R. (2005). Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology, 129 (6), 1937-1943. doi: 10.1053/j.gastro.2005.09.015

Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis

Clouston, Andrew D., Powell, Elizabeth E., Walsh, Meagan J., Richardson, Michelle M., Demetris, A. Jake and Jonsson, Julie R. (2005). Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis. Hepatology, 41 (4), 809-818. doi: 10.1002/hep.20650

A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C

Richardson, M. M., Powell, E. E., Barrie, H. D., Clouston, A. D., Purdie, D. M. and Jonsson, J. R. (2005). A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. Journal of Medical Genetics, 42 (7), 1-6. doi: 10.1136/jmg.2005.032557

Adiponectin and its receptors in patients with chronic hepatitis C

Jonsson, JR, Moschen, AR, Hickman, IJ, Richardson, MM, Kaser, S, Clouston, AD, Powell, EE and Tilg, H (2005). Adiponectin and its receptors in patients with chronic hepatitis C. Journal of Hepatology, 43 (6), 929-936. doi: 10.1016/j.jhep.2005.05.030

Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver disease

Powell, EE, Jonsson, JR and Clouston, AD (2005). Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver disease. Annals of Internal Medicine, 143 (10), 753-754. doi: 10.7326/0003-4819-143-10-200511150-00015

Steatosis: Co-factor in other liver diseases

Powell, EE, Jonsson, JR and Clouston, AD (2005). Steatosis: Co-factor in other liver diseases. Hepatology, 42 (1), 5-13. doi: 10.1002/hep.20750

Nonalcoholic fatty liver disease: is all the fat bad?

Clouston, A. D. and Powell, E. E. (2004). Nonalcoholic fatty liver disease: is all the fat bad?. Internal Medicine Journal, 34 (4), 187-191. doi: 10.1111/j.1444-0903.2004.00574.x

Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection

Jonsson, Julie R., Gu, Wenyi, Vanags, Daina M., Bishop, G. Alex, McCaughan, Geoffrey W., Fawcett, Jonathon, Lynch, Stephen V., Balderson, Glenda A., Powell, Elizabeth E. and Clouston, Andrew D. (2004). Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transplantation, 10 (3), 397-403. doi: 10.1002/lt.20084

Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study

Buntain, HM, Greer, RM, Schluter, PJ, Wong, JCH, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE and Bell, SC (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax, 59 (2), 149-155. doi: 10.1136/thorax.2003.006726

Association between apolipoprotein E epsilon 4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C

Gochee, Peter A., Powell, Elizabeth E., Purdie, David M., Pandeya, Nirmala, Kelemen, Livia, Shorthouse, Claudia, Jonsson, Julie R. and Kelly, Brian (2004). Association between apolipoprotein E epsilon 4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics, 45 (1), 49-57. doi: 10.1176/appi.psy.45.1.49

CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitis

Eri, R, Jonsson, JR, Pandeya, N, Purdie, DM, Clouston, AD, Martin, N, Duffy, D, Powell, EE, Fawcett, J, Florin, THJ and Radford-Smith, GL (2004). CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitis. Genes And Immunity, 5 (6), 444-450. doi: 10.1038/sj.gene.6364113

Chronic hepatitis C and steatosis

Clouston, A. D., Jonsson, J. R. and Powell, E. (2004). Chronic hepatitis C and steatosis. Current Hepatitis Reports, 3 (4), 123-128.

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

Hickman, IJ, Jonsson, JR, Prins, JB, Ash, S, Purdie, DM, Clouston, AD and Powell, EE (2004). Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut, 53 (3), 413-419. doi: 10.1136/gut.2003.027581

Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury

Walsh, MJ, Vanags, DM, Clouston, AD, Richardson, MM, Purdie, DM, Jonsson, JR and Powell, EE (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury. Hepatology, 39 (5), 1230-1238. doi: 10.1002/hep.20179

Virus-specific CD8+ T lymphocytes within the normal human liver

Ward, S. M., Jonsson, J. R., Sierro, S., Clouston, A. D., Lucas, M., Vargas, A. L., Powell, E. E. and Klenerman, P. (2004). Virus-specific CD8+ T lymphocytes within the normal human liver. European Journal of Immunology, 34 (6), 1526-1531. doi: 10.1002/eji.200324275

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy

Hickman, I. J., Powell, E. E., Prins, J. B., Clouston, A. D., Ash, S., Purdie, D. M. and Jonsson, J. R. (2003). In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. Journal of Hepatology, 39 (6), 1042-1048. doi: 10.1016/S0168-8278(03)00463-X

Fatty liver disease: The next epidemic?

Hickman, Ingrid and Powell, Elizabeth (2003). Fatty liver disease: The next epidemic?. Medicine Today, 4 (2), 40-47.

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001

Law M.G., Dore G.J., Bath N., Thompson S., Crofts N., Dolan K., Giles W., Gow P., Kaldor J., Loveday S., Powell E., Spencer J. and Wodak A. (2003). Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology, 32 (5), 717-724. doi: 10.1093/ije/dyg101

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese

Dixon, JB, Bhathal, PS, Jonsson, JR, Dixon, AF, Powell, EE and O'Brien, PE (2003). Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. Journal of Hepatology, 39 (6), 967-971. doi: 10.1016/S0168-8278(03)00459-8

Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1

Gochee, P. A., Jonsson, J. R., Clouston, A. D., Pandeya, N., Purdie, D. M. and Powell, E. E. (2003). Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1. Journal of Gastroenterology And Hepatology, 18 (4), 386-392. doi: 10.1046/j.1440-1746.2003.02984.x

Lymphocyte apoptosis and cell replacement in human liver allografts

Clouston, Andrew D., Jonsson, Julie R., Balderson, Glenda A., Fawcett, Jonathon, Lynch, Stephen V., Kelso, Anne and Powell, Elizabeth E. (2002). Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation, 73 (11), 1828-1834. doi: 10.1097/00007890-200206150-00022

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

Hickman, I. J., Clouston, A. D.., Macdonald, G. A., Purdie, D. M., Prins, J. B., Ash, S., Jonsson, J. R. and Powell, E. E. (2002). Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 51 (1), 89-94. doi: 10.1136/gut.51.1.89

Interaction of non-alcoholic fatty liver disease with other liver diseases

Clouston, AD and Powell, EE (2002). Interaction of non-alcoholic fatty liver disease with other liver diseases. Bailliere's Best Practice and Research in Clinical Gastroenterology, 16 (5), 767-781. doi: 10.1053/bega.2002.0329

Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' reply

Clouston, Andrew D., Hickman, Ingrid J., Macdonald, Graeme A., Jonsson, Julie R. and Powell, Elizabeth E. (2001). Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' reply. Journal of Hepatology, 35 (3), 433-433. doi: 10.1016/S0168-8278(01)00116-7

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

Jonsson, Julie R., Clouston, Andrew D., Ando, Yuichi, Kelemen, Livia I., Horn, Murray J., Adamson, Michael D., Purdie, David M. and Powell, Elizabeth E. (2001). Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology, 121 (1), 148-155. doi: 10.1053/gast.2001.25480

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

Clouston, Andrew D., Jonsson, Julie R., Purdie, David M., Macdonald, Graeme A., Pandeya, Nirmala, Shorthouse, Claudia and Powell, Elizabeth E. (2001). Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. Journal of Hepatology, 34 (2), 314-320. doi: 10.1016/S0168-8278(00)00096-9

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

Jonsson, Julie R., Hong, Cui, Purdie, David M., Hawley, Carmel, Isbel, Nicky, Butler, Maree, Balderson, Glenda A., Clouston, Andrew D., Pandeya, Nirmala, Stuart, Katherine, Edwards-Smith, Catherine, Crawford, Darrel H., Fawcett, Jonathon and Powell, Elizabeth E. (2001). Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transplantation, 7 (3), 255-263. doi: 10.1053/jlts.2001.22450

Novel Surveillance and Cure of A Donor-Transmitted Lymphoma in A Renal Allograft Recipient

Herzig, Karen A., Falk, Michael C., Jonsson, Julie R., Axelsen, Roy A., Griffin, Anthony D., Hawley, Carmel M., Rigby, Russell J., Cobcroft, Ralph, Nicol, David L., Powell, Elizabeth E. and Johnson, David W. (2000). Novel Surveillance and Cure of A Donor-Transmitted Lymphoma in A Renal Allograft Recipient. Transplantation, 70 (1), 149-152.

Detection of male DNA in the liver of female patients with primary biliary cirrhosis

Fanning, Peter A., Jonsson, Julie R., Clouston, Andrew D., Edwards-Smith, Cathy, Balderson, Glenda A., Macdonald, Graeme A., Crawford, Darrell H. G., Kerlin, Paul, Powell, Lawrie W. and Powell, Elizabeth E. (2000). Detection of male DNA in the liver of female patients with primary biliary cirrhosis. Journal of Hepatology, 33 (5), 690-695. doi: 10.1016/S0168-8278(00)80297-4

Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes

Jonsson, J. R., Edwards-Smith, C. J., Catania, S. C., Morotomi, Y., Hogan, P. G., Clouston, AD, Bansal, A. S., Lynch, S. V., Strong, R. W. and Powell, E. E. (2000). Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes. Journal of Hepatology, 32 (3), 392-398. doi: 10.1016/S0168-8278(00)80388-8

Host genetic factors influence disease progression in chronic hepatitis C

Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M. and Jonsson, J. R. (2000). Host genetic factors influence disease progression in chronic hepatitis C. Hepatology, 31 (4), 828-833. doi: 10.1053/he.2000.6253

Steatosis and chronic hepatitis C: Analysis of fibrosis and stellate cell activation

Clouston, AD, Jonsson, JR, Purdie, DM, Macdonald, G, Pandeya, N, Shorthouse, C and Powell, EE (2000). Steatosis and chronic hepatitis C: Analysis of fibrosis and stellate cell activation. Hepatology, 32 (4), 504A-504A.

Correspondence: Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

Jonsson, J. R., Hourigan, L. F., Purdie, D. M., Clouston, A. D., Macdonald, G. A. and Powell, E. E. (1999). Correspondence: Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients. Hepatology, 30 (6), 1530-1531. doi: 10.1002/hep.510300625

Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy

Maguire, C. M., Crawford, D. H. G., Hourigan, L. F., Clouston, A. D., Walpole, E. T. and Powell, E. E. (1999). Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy. Journal of Gastroenterology and Hepatalogy, 14 (8), 801-803. doi: 10.1046/j.1440-1746.1999.01961.x

Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C

Bell, Trudi, Bansal, Amolak, Shorthouse, Claudia, Sandford, Neville and Powell, Elizabeth (1999). Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C. Journal of Gastroenterology and Hepatology, 14 (5), 419-422. doi: 10.1046/j.1440-1746.1999.01896.x

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. L. J., Shorthouse, C., Clouston, A. and Powell, E. E. (1999). Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology, 29 (4), 1215-1219. doi: 10.1002/hep.510290401

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to inferferon alfa.

Edwards-Smith, C. J., Jonsson, J. R., Purdie, D. M., Bansal, A., Shorthouse, C. and Powell, E. (1999). Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to inferferon alfa.. Hepatology, 30 (2), 526-530. doi: 10.1002/hep.510300207

Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation

Jonsson, J. R., Gill, D., Hogan, P. G., Clouston, A. D., Edwards-Smith, C. J., Griffin, A. D., Balderson, G. A., Lynch, S. V., Strong, R. W. and Powell, E. E. (1999). Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation. Transplantation, 67 (10), 1358-1361. doi: 10.1097/00007890-199905270-00011

Body mass index and steatosis are associated with fibrosis in chronic hepatitis C

Hourigan, L. F., Macdonald, G. A., Purdie, D., Shorthouse, C., Clouston, A. and Powell, E. E. (1998). Body mass index and steatosis are associated with fibrosis in chronic hepatitis C. Hepatology, 28 (4, Part 2 Suppl.), 685A-685A.

Human liver transplant perfusate: An abundant source of donor liver-associated leukocytes

Jonsson, J.R., Hogan, P. G., Balderson, G. A., Ooi, .L. L., Lynch, S. V., Strong, R. W. and Powell, E. E. (1997). Human liver transplant perfusate: An abundant source of donor liver-associated leukocytes. Hepatology, 26 (5), 1111-1114. doi: 10.1002/hep.510260504

Peripheral blood chimerism following human liver transplantation

Jonsson, JR, HoganPG, ThomasR, SteadmanC, CloustonAD, BaldersonGA, LynchSV, StrongRW and PowellEE (1997). Peripheral blood chimerism following human liver transplantation. Hepatology, 25 (5), 1233-1236. doi: 10.1002/hep.510250528

Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-γ is elevated in patients with hepatitis C infection

Bansal A.S., Bruce J., Hogan P.G., Prichard P. and Powell E.E. (1997). Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-γ is elevated in patients with hepatitis C infection. Clinical Immunology and Immunopathology, 84 (2), 139-144. doi: 10.1006/clin.1997.4371

Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient

Burt, M., Jazwinska, E., Lynch, S., Kerlin, P., Gill, D., Steadman, C., Jonsson, J., Strong, R. and Powell, E. (1996). Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient. Liver Transplantation and Surgery, 2 (5), 391-394. doi: 10.1002/lt.500020511

Crosses of Nod Mice with the Related Non Strain - a Polygenic Model for Iddm

McAleer, MA, Reifsnyder, P, Palmer, SM, Prochazka, M, Love, JM, Copeman, JB, Powell, EE, Rodrigues, NR, Prins, JB, Serreze, DV, Delarato, NH, Wicker, LS, Peterson, LB, Schork, NJ, Todd, JA and Leiter, EH (1995). Crosses of Nod Mice with the Related Non Strain - a Polygenic Model for Iddm. Diabetes, 44 (10), 1186-1195. doi: 10.2337/diabetes.44.10.1186

Successful In-Vitro Fertilization and Pregnancy in a Patient with Autoimmune Chronic Active Hepatitis and Cirrhosis

Powell, EE and Molloy, D (1995). Successful In-Vitro Fertilization and Pregnancy in a Patient with Autoimmune Chronic Active Hepatitis and Cirrhosis. Journal of Gastroenterology and Hepatology, 10 (2), 233-235. doi: 10.1111/j.1440-1746.1995.tb01084.x

Susceptibility to Human Type-1 Diabetes At Iddm2 Is Determined by Tandem Repeat Variation At the Insulin Gene Minisatellite Locus

Bennett, ST, Lucassen, AM, Gough, Scl, Powell, EE, Undlien, DE, Pritchard, LE, Merriman, ME, Kawaguchi, Y, Dronsfield, MJ, Pociot, F, Nerup, J, Bouzekri, N, Cambonthomsen, A, Ronningen, KS, Barnett, AH, Bain, SC and Todd, JA (1995). Susceptibility to Human Type-1 Diabetes At Iddm2 Is Determined by Tandem Repeat Variation At the Insulin Gene Minisatellite Locus. Nature Genetics, 9 (3), 284-292. doi: 10.1038/ng0395-284

Reply to “Insulin expression: Is VNTR allele 698 really anomalous?”

Bennett, Simon T., Lucassen, Anneke M., Gough, Stephen C.L., Powell, Elizabeth E., Pritchard, Lynn E., Merriman, Marilyn E., Kawaguchi, Yoshihiko, Todd, John A., Undlien, Dag E., Rønningen, Kjersti S., Pociot, Flemming, Nerup, Jørn, Bouzekri, Nourdine, Cambon-Thomsen, Anne, Dronsfield, Mark J., Barnett, Anthony H. and Bain, Stephen C. (1995). Reply to “Insulin expression: Is VNTR allele 698 really anomalous?”. Nature Genetics, 10 (4), 379-380. doi: 10.1038/ng0895-379

Allelic Variation of the Type-2 Tumor-Necrosis-Factor Receptor Gene

Powell, EE, Wicker, LS, Peterson, LB and Todd, JA (1994). Allelic Variation of the Type-2 Tumor-Necrosis-Factor Receptor Gene. Mammalian Genome, 5 (11), 726-727. doi: 10.1007/BF00426081

Chromosome-Specific Microsatellite Sets for Fluorescence-Based, Semiautomated Genome Mapping

Reed, PW, Davies, JL, Copeman, JB, Bennett, ST, Palmer, SM, Pritchard, LE, Gough, Scl, Kawaguchi, Y, Cordell, HJ, Balfour, KM, Jenkins, SC, Powell, EE, Vignal, A and Todd, JA (1994). Chromosome-Specific Microsatellite Sets for Fluorescence-Based, Semiautomated Genome Mapping. Nature Genetics, 7 (3), 390-395. doi: 10.1038/ng0794-390

Low-Density-Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme-A Reductase Gene-Expression in Human Mononuclear Leukocytes Is Regulated Coordinately and Parallels Gene-Expression in Human Liver

Powell, EE and Kroon, PA (1994). Low-Density-Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme-A Reductase Gene-Expression in Human Mononuclear Leukocytes Is Regulated Coordinately and Parallels Gene-Expression in Human Liver. Journal of Clinical Investigation, 93 (5), 2168-2174. doi: 10.1172/JCI117213

Measurement of mRNA by quantitative PCR with a nonradioactive label

Powell, Elizabeth E. and Kroon, Peter A. (1992). Measurement of mRNA by quantitative PCR with a nonradioactive label. Journal of Lipid Research, 33 (4), 609-614. doi: 10.1016/s0022-2275(20)41626-8

Liver, Lipoproteins and Disease .2. Clinical Relevance of Disordered Cholesterol-Metabolism in Liver-Disease

Powell, EE and Kroon, PA (1992). Liver, Lipoproteins and Disease .2. Clinical Relevance of Disordered Cholesterol-Metabolism in Liver-Disease. Journal of Gastroenterology and Hepatology, 7 (2), 225-231. doi: 10.1111/j.1440-1746.1992.tb00966.x

Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism

Kroon, PA and Powell, EE (1992). Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism. Journal of Gastroenterology and Hepatology, 7 (2), 214-224. doi: 10.1111/j.1440-1746.1992.tb00965.x

Markers of Chronic Alcohol Ingestion in Patients with Nonalcoholic Steatohepatitis - An Aid to Diagnosis

Fletcher, L. M., Kwohgain, I., Powell, E. E., Powell, L. W. and Halliday, J. W. (1991). Markers of Chronic Alcohol Ingestion in Patients with Nonalcoholic Steatohepatitis - An Aid to Diagnosis. Hepatology, 13 (3), 455-459. doi: 10.1016/0270-9139(91)90298-A

Improvement in Chronic Hepatocerebral Degeneration Following Liver Transplantation

Powell, Elizabeth E., Pender, Michael P., Chalk, Jonathan B., Parkin, Philip J., Strong, Russell, Lynch, Stephen, Kerlin, Paul, Cooksley, W. Graham, Cheng, Wendy and Powell, Lawrie W. (1990). Improvement in Chronic Hepatocerebral Degeneration Following Liver Transplantation. Gastroenterology, 98 (4), 1079-1082. doi: 10.1016/0016-5085(90)90036-Z

Not all fatty livers are benign: Reply

Powell, E. E. (1990). Not all fatty livers are benign: Reply. Gastroenterology, 99 (1)

Reply

Powell, E. E. (1990). Reply. Gastroenterology, 99 (1) doi: 10.1016/0016-5085(90)91267-A

The Natural-History of Nonalcoholic Steatohepatitis - a Follow-Up-Study of 42 Patients for Up to 21 Years

Powell, EE, Cooksley, Wge, Hanson, R, Searle, J, Halliday, JW and Powell, LW (1990). The Natural-History of Nonalcoholic Steatohepatitis - a Follow-Up-Study of 42 Patients for Up to 21 Years. Hepatology, 11 (1), 74-80. doi: 10.1002/hep.1840110114

Steatohepatitis Associated with Limb Lipodystrophy

Powell, EE, Searle, J and Mortimer, R (1989). Steatohepatitis Associated with Limb Lipodystrophy. Gastroenterology, 97 (4), 1022-1024.

Lupus Anticoagulant

Yap, AS, Powell, EE, Yelland, CE, Mortimer, RH and Perrykeene, DA (1989). Lupus Anticoagulant. Annals of Internal Medicine, 111 (3), 262-263. doi: 10.7326/0003-4819-111-3-262

Steatohepatitis associated with limb lipodystrophy

Powell, Elizabeth E., Searle, Jeffrey and Mortimer, Robin (1989). Steatohepatitis associated with limb lipodystrophy. Gastroenterology, 97 (4), 1022-1024. doi: 10.1016/0016-5085(89)91513-8

Hepatitis-B Transmission Within Families - Potential Importance of Saliva as a Vehicle of Spread

Powell, E, Duke, M and Cooksley, Wge (1985). Hepatitis-B Transmission Within Families - Potential Importance of Saliva as a Vehicle of Spread. Australian and New Zealand Journal of Medicine, 15 (6), 717-720.

DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTER

Lankford, Allison, Gerding, James, Jones, Kevin, Cires-Drouet, Rafael, Tran, Quincy, Haase, Daniel, Nagarsheth, Khanjan, Naselsky, Warren, Jayanathan, Mark, Drummond, Rosa and Powell, Elizabeth (2023). DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTER. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENT

Haase, Daniel, Widjaja, Austin, Aquino, Alexa, Aligabi, Ayah, Bzhilyanskaya, Vera, Epstein, Jacob, Faisal, Manal, Kowansky, Taylor, Lin, Yiting, Okolo, Robinson, Plotnikova, Anya, Quackenbush, Jane, Sahadzic, Iana, Singh, Aditi, Tang, Kaitlyn, Yardi, Isha, Niles, Erin, Hart, Emily, Powell, Elizabeth and Tran, Quincy (2023). IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENT. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORT

Ramadan, Leena, Shi, Tesia, Esposito, Emily, Powell, Elizabeth, Tran, Quincy, Motta, Melissa, Scalea, Thomas and Tabatabai, Ali (2023). PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORT. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD

McKillen, B., Elangovan, H., Horsfall, L., Patel, P., Hayward, K., Clouston, A., Radford-Smith, D., Valery, P., Britton, L., Brown, N., Bernard, A. and Powell, E. (2019). A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA Australia, 8–10 September 2019. Richmond, VIC Australia: Wiley-Blackwell.

Health-related quality of life in patients with cirrhosis

Amarasena, S., Bernardes, C., Stuart, K., Gupta, R., Horsfall, L., Rahman, T., Clark, P., Skoien, R., Hartel, G., Hayward, K., Powell, E. and Valery, P. (2019). Health-related quality of life in patients with cirrhosis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Online, 21–30 November 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.15269

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation

Iyer, Abishek, Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J. and Fairlie, David P. (2019). Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation. Experimental Biology Meeting (EB), Orlando Fl, Apr 06-09, 2019. HOBOKEN: WILEY.

Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores

Patel, Preya, Cheng, Johnson Chieh-Yu, Banh, Xuan, Hossain, Fabrina, Horsfall, Leigh Ula, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine A., Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine, Clouston, Andrew D., Bernard, Anne and Powell, Elizabeth E. (2018). Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) / Liver Meeting, San Francisco, CA United States, 9-13 November 2018. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1002/hep.30257

Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?

Patel, P. J., Smith, D. D., Stuart, K. A., Horsfall, L. U., Hayward, K. L., Hossain, F., Williams, S., Johnson, T., Brown, N. N., Saad, N., Clouston, A. D., Irvine, K. M., Russell, A. W., Valery, P. C. and Powell, E. E. (2017). Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?. International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands, 19-23 April 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(17)31602-1

Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes

Patel, P. J., Stuart, K. A., Horsfall, L. U., Hayward, K. L., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Saad, N., Clouston, A., Irvine, K. M., Russell, A., Valery, P. C. and Powell, E. E. (2017). Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes. Gastroenterological Society of Australia Australian Gastroenterology Week Precision Medicine in Gastroenterology, Gold Coast, QLD Australia, 20 - 22 August 2017. Richmond, VIC Australia: Wiley-Blackwell.

Medication adherence in outpatients with decompensated cirrhosis

Hayward, K. L., Cottrell, W. N., Karmakar, A., Patel, P. J., Horsfall, L. U., Martin, J. H., Irvine, K. M., Tallis, C. J., Wright, P. L., Stuart, K. A., Valery, P. C. and Powell, E. E. (2016). Medication adherence in outpatients with decompensated cirrhosis. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, SA Australia, 10–12 October 2016. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.13520

Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes

Patel, P. J., Stuart, K. A., Horsfall, L. U., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Clouston, A., Irvine, K. M., Russell, A. and Powell, E. E. (2016). Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, South Australia, Australia, 10–12 October, 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13520

An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

Valery, P. C., Clark, P. J., Mcphail, S. M., Martin, J., Horsfall, L., Volk, M. L. and Powell, E. (2015). An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. HOBOKEN: WILEY-BLACKWELL.

Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation

Irvine, K. M., Clouston, A. D., Blumenthal, A. and Powell, E. E. (2015). Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD, Australia, 28 September - 2 October 2015. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/jgh.13087

Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injury

Irvine, Katharine, Clouston, Andrew D., Blumenthal, Antje and Powell, Elizabeth E. (2015). Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injury. 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, United States, Nov 13-17, 2015. Hoboken, United States: John Wiley & Sons.

Discrepancies in the use of medications in patients with cirrhosis

Hayward, K., Valery, P. C., Cottrell, N., Irvine, K., Horsfall, L., Ruffin, B., Tallis, C., Chachay, V., Martin, J. and Powell, E. (2015). Discrepancies in the use of medications in patients with cirrhosis. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD Australia, 28 September - 2 October 2015. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.13093

Economic consideration for reducing hospital presentations among patients with decompensated cirrhosis: not all presentations avoided can be considered equal

Mcphail, S. M., Horsfall, L., Irvine, K., Fagan, K. J. and Powell, E. E. (2015). Economic consideration for reducing hospital presentations among patients with decompensated cirrhosis: not all presentations avoided can be considered equal. Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015 World Congress of Gastroenterology, Brisbane, Queensland, Australia, 28 September-2 October 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13093

Patterns of service utilisation within hepatology clinics: high prevalence of advanced liver disease

El-Atem, N., Wojcik, K., Horsfall, L., Irvine, K., Johnson, T., Mcphail, S. M. and Powell, E. E. (2015). Patterns of service utilisation within hepatology clinics: high prevalence of advanced liver disease. Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015 | World Congress of Gastroenterology, Brisbane, Queensland, Australia, 28 September-2 October 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13093

Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores

Irvine, Katharine, Wockner, Leesa F., Shanker, Mihir, Fagan, Kevin, Horsfall, Leigh, Fletcher, Linda, Ungerer, Jacobus, Pretorius, Carel J., Miller, Gregory, Clouston, Andrew D., Lampe, Guy and Powell, Elizabeth E. (2015). Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores. 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, United States, 13-17 November 2015. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.28218

Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores

Irvine, K. M., Wockner, L. F., Shanker, M., Fagan, K. J., Horsfall, L. U., Fletcher, L. M., Ungerer, J., Pretorius, C. J., Miller, G. C., Clouston, A. D., Lampe, G. and Powell, E. E. (2015). Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores. Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015 | World Congress of Gastroenterology, Brisbane, Queensland, Australia, 28 September-2 October 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13093

An ELF score of >= 9.8 can identify advanced fibrosis in Australian patients with chronic liver disease

Fagan, K., Horsfall, L., Irvine, K., Fletcher, L., Tate, J., Choi, K., Nusrat, S., Melino, M., Clouston, A., Ballard, E., O'Rourke, P., Lampe, G., Ungerer, J. and Powell, E. (2014). An ELF score of >= 9.8 can identify advanced fibrosis in Australian patients with chronic liver disease. Australian Gastroenterology Week 2014, UnknownGold Coast Convention & Exhibition Centre, Broadbeach, Queensland, 22-24 October. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Microbial burden is associated with clinical outcomes and reduced ascites innate immune cells in non-infected ascites

Fagan, K. J., Melino, M., Powell, E. E. and Irvine, K. M. (2014). Microbial burden is associated with clinical outcomes and reduced ascites innate immune cells in non-infected ascites. Australian Gastroenterology Week 2014, Broadbeach, QLD Australia, 22-24 October 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12736_5

Spaciotemporal characterization of the cellular and molecular contributors to chronic hepatic fibrosis in a hepatotoxin-induced mouse model

Melino, M., Gadd, V., Martinez, M., Lineburg, K., Irvine, K., Clouston, A. D., Powell, E. E. and Macdonald, K. P. (2014). Spaciotemporal characterization of the cellular and molecular contributors to chronic hepatic fibrosis in a hepatotoxin-induced mouse model. Australian Gastroenterology Week 2014, Broadbeach, QLD Australia, 22-24 October 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12736

The Portal Inflammatory Infiltrate and Ductular Niche in Non-Alcoholic Fatty Liver Disease

Gadd, Victoria L., Skoien, Richard, Fagan, Kevin, Irvine, Katharine, Powell, Elizabeth E. and Clouston, Andrew D. (2013). The Portal Inflammatory Infiltrate and Ductular Niche in Non-Alcoholic Fatty Liver Disease. 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington Dc, Nov 01-05, 2013. HOBOKEN: WILEY-BLACKWELL.

Assessment of alcohol histories obtained from patients with liver disease: Opportunities to improve early intervention

Fagan, K., Irvine, K., Kumar, S., Bates, A., Horsfall, L., Feeney, G. and Powell, E. (2013). Assessment of alcohol histories obtained from patients with liver disease: Opportunities to improve early intervention. Australian Gastroenterology Week 2013, Melbourne, Australia, 7-9 October 2013. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_5

Association of IFNL3 polymorphisms with fibrosis progression in viral and non-viral chronic liver disease

Eslam, M., Leung, R., Berg, T., Irving, W. L., Mangia, A., Sheridan, D., Abate, M. L., Weltman, M., Spengler, U., Mollison, L., Cheng, W., Dore, G. J., Powell, E., Riordan, S., Douglas, M., Suppiah, V., Stewart, G. J., Booth, D. R., George, J. and Ahlenstiel, G. (2013). Association of IFNL3 polymorphisms with fibrosis progression in viral and non-viral chronic liver disease. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_5

BMI but not aetiology or stage of liver disease affects the diagnostic sensitivity of carbohydrate deficient transferrin

Fagan, K., Irvine, K., McWhinney, B., Fletcher, L., Horsfall, L., Johnson, L., Clouston, A., Jonsson, J., O'Rourke, P., Martin, J., Pretorius, C., Ungerer, J. and Powell, E. (2013). BMI but not aetiology or stage of liver disease affects the diagnostic sensitivity of carbohydrate deficient transferrin. International Liver Congress / 48th Annual Meeting of the European Association for the Study of the Liver (EASL), Amsterdam, Netherlands, 24-28 April 2013. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(13)60527-9

Factors associated with mortality and unplanned hospital readmissions in patients with ascites

Zhao, E., Horsfall, L., Ruffin, B. J., Fagan, K. J., Irvine, K. M. and Powell, E. E. (2013). Factors associated with mortality and unplanned hospital readmissions in patients with ascites. Australian Gastroenterology Week 2013, Melbourne, Australia, 7-9 October 2013. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_5

The portal inflammatory infiltrate and ductular niche in non-alcoholic fatty liver disease

Gadd, V., Skoien, R., Fagan, K., Irvine, K., Powell, E. and Clouston, A. (2013). The portal inflammatory infiltrate and ductular niche in non-alcoholic fatty liver disease. Australian Gastroenterology Week 2013, Melbourne Australia, 7-9 October 2013. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365

A simple scoring system accurately excludes portal fibrosis in non-alcoholic fatty liver disease

Skoien, R., Rich, G. G., Horsfall, L., Jonsson, J. R., Clouston, A. D., George, J. and Powell, E. E. (2012). A simple scoring system accurately excludes portal fibrosis in non-alcoholic fatty liver disease. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, Spain, 18-22 April 2012. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(12)61081-2

Attitudes towards non-alcoholic fatty liver disease amongst non-hepatology specialists in two major Australian hospitals

Bergqvist, C. J., Skoien, R., Horsfall, L., Jonsson, J. R. and Powell, E. E. (2012). Attitudes towards non-alcoholic fatty liver disease amongst non-hepatology specialists in two major Australian hospitals. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, Spain, 18-22 April 2012. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(12)61333-6

CDT as a biomarker of alcohol excess in patients with chronic liver disease: BMI affects diagnostic sensitivity

Fagan, Kevin, McWhinney, Brett, Horsfall, Leigh, Ungerer, Jacobus P., Pretorius, Carel J., Johnson, Lambro A., Clouston, Andrew, Fletcher, Linda M., Jonsson, Julie, O'Rourke, Peter and Powell, Elizabeth (2012). CDT as a biomarker of alcohol excess in patients with chronic liver disease: BMI affects diagnostic sensitivity. Australian Gastroenterology Week 2012, Adelaide, SA Australia, 16-19 October 2012. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_5.x

Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis

Gadd, V.L., Roy, S., Clouston, A. D., Melino, M., Jonsson, J. R. and Powell, E. E. (2011). Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL.

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

Melino, Michelle, Gadd, Victoria L., Thomas, G. P., Walker, Gene V., Skoien, Richard, Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2011). Macrophage secretory products induce an inflammatory phenotype in hepatocytes. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL.

Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis

Skoien, R., Powell, E. E., Melino, M., Clouston, A. D., Gabrielli, B. G. and Jonsson, J. R. (2010). Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis. Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/j.1440-1746.2010.06450.x

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

Skoien, R., Richardson, M. M., Jonsson, J. R., Powell, E. E. and Clouston, A. D. (2010). Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Australian Gastroenterology Week 2010, Broadbeach, Qld., Australia, 20-23 October 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06457.x

Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis

Melino, M., Powell, E. E., Gadd, V. L., Skoien, R., Walker, G., Clouston, A. D. and Jonsson, J. R. (2010). Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis. AGW2010: Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October, 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06450.x

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

Powell, Elizabeth E., Jonsson, Julie R. and Clouston, Andrew D. (2010). Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Falk Symposium 171 on Liver and Metabolic Syndrome, Hannover, Germany, 15-18 October 2009. Basel, Switzerland: S. Karger AG. doi: 10.1159/000282084

IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis

Fritz, Teresa, Moschen, Alexander R., Jonsson, Julie R., Woerz, Ilka, Clouston, Andrew D., Kim, SooHyun, Dinarello, Charles A., Bartenschlager, Ralf, Powell, Elizabeth E. and Tilg, Herbert (2009). IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis. 60th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, U.S.A., 30 October - 3 November 2009. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.23300

Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis

McPherson, S., Cowin, G., O'Rourke, P., Volp, A., Horsfall, L., Burke, L., Jonsson, J., Clouston, A., Fawcett, J., Galloway, G., Benson, M. and Powell, E. (2009). Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen Denmark, Apr 22-26, 2009. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(09)61011-4

Quantitation of steatosis by magnetic resonance imaging (MRI) and spectroscopy (MRS) in liver disease: effect of hepatic fibrosis and iron

McPherson, S., Cowin, G., O'Rourke, P., Volp, A., Horsfall, L., Burke, L., Jonsson, J.R., Clouston, A., Fawcett, J., Galloway, G., Benson, M. and Powell, E. (2009). Quantitation of steatosis by magnetic resonance imaging (MRI) and spectroscopy (MRS) in liver disease: effect of hepatic fibrosis and iron. Annual Meeting of the British Society of Gastroenterology, Glasgow, Scotland, 23-26 March 2009. London, United Kingdom: B M J Group.

Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment

Richardson, M., Jonsson, J., Powell, E., Brunt, E. M., Bhathal, P., Dixon, J. and Clouston, A. (2005). Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 11-15 November 2005. HOBOKEN: JOHN WILEY & SONS INC.

Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis C

Walsh, M.J., Jonsson, J.R., Richardson, M.M., Lipka, G.M., Purdie, D.M., Clouston, A.D. and Powell, E.E. (2005). Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis C. 40th Annual Meeting of the European Association for the Study of the Liver, Paris, France, 13-17 April 2005. Amsterdam , Netherlands: Elsevier.

Factors affecting the gene expression of hepcidin in chronic viral hepatitis C

Bridle, K. R., Fletcher, L. M., Jonsson, J. R., Richardson, M. M., Clouston, A. D., Powell, E. E. and Crawford, D. H. G. (2004). Factors affecting the gene expression of hepcidin in chronic viral hepatitis C. Australian Gastroenterology Week 2004, Brisbane Convention Centre, Brisbane, Qld Australia, 4-8 October, 2004. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2004.3615_3..x

Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism

Clouston, A., Vanags, D. M., Gu, W. Y., Powell, E. E. and Jonsson, J. R. (2003). Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons.

Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success

Hickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D. and Powell, E. E. (2003). Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success. 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.1840380507

Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression

Clouston, A. D., Jonsson, J. R., Letizia, B., Richardson, M. M., Vanags, D. M., Walsh, M., Demetris, A. J. and Powell, E. E. (2003). Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons.

The CCR5 delta 32 mutation is strongly associated with primary sclerosing cholangitis

Eri, RD, Jonsson, J, Pandeya, N, Purdie, D, Robinson, J, Martin, N, Powell, E, Fawcett, J and Radford-Smith, G (2002). The CCR5 delta 32 mutation is strongly associated with primary sclerosing cholangitis. PHILADELPHIA: W B SAUNDERS CO.

Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels

Jonsson, J. R., Hickman, I. J., Clouston, A. D., Ash, S., Prins, J., Pandaya, N., Purdie, D. M. and Powell, E. E. (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels. 53rd Annual Meeting of the Association for the Study of Liver-Diseases (AASLD), Boston, M.A. USA, 01-05 November 2002. Hoboken, NJ United States: John Wiley and Sons.

Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levels

Hickman, Ingrid, Powell, Elizabeth, Clouston, Andrew, Ash, Susan, Pandaya, Nirmala, Purdie, David and Jonsson, Julie (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levels. *, *, *. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(02)80611-0

Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease

Hickman, I., Powell, E., Jonsson, J. and Ash, S. (2002). Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease. -, -, -. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(02)80922-9

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

Hickman, Ingrid, Clouston, Andrew, Ash, Susan, MacDonald, Graeme, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction improves biochemistry and histology in patients with chronic hepatitis C. Nutrition Week: A Scientific and Clinical Forum and Exposition, Bethesda, MD, 2002. Bethesda, MD: American Society for Nutrition.

Weight reduction in patients with chronic HCV reduces circulating insulin levels

Hickman, Ingrid, Clouston, Andrew, Macdonald, Graeme, Ash, Susan, Prins, John, Purdie, David, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction in patients with chronic HCV reduces circulating insulin levels. -, Milan, Italy, April 18th, 2002. Ireland Ltd.: Elsevier Science. doi: 10.1016/S0168-8278(02)80921-7

Expression of the hepatic renin angiotensin system in chronic hepatitis C

Jonsson, J. R., Clouston, A., Gochee, P. and Powell, E. (2001). Expression of the hepatic renin angiotensin system in chronic hepatitis C. Asia Pacific Digestive Week 2001, Sydney, 23-27 Sep, 2001. Asia: Blackwell Science.

Expression of the hepatic renin angiotensin system in chronic hepatitis C

Jonsson, J. R., Clouston, A., Gochee, P. and Powell, E. (2001). Expression of the hepatic renin angiotensin system in chronic hepatitis C. AASLD 52nd Annual Meeting, Dallas, Texas, USA, 9-13 November, 2001. Philadelphia: W B Saunders.

Expression of the hepatic renin angiotensin system in chronic hepatits C

Jonsson, J. R., Clouston, A. D., Gochee, P. A. and Powell, E. E. (2001). Expression of the hepatic renin angiotensin system in chronic hepatits C. -, -, -. PHILADELPHIA: W B SAUNDERS CO.

Hepatitis C - host factors affecting progressive fibrosis

Clouston, A., Jonsson, J. R., Hickman, P. E. and Powell, E. (2001). Hepatitis C - host factors affecting progressive fibrosis. 6th Banff Consensus Conference on Allograft Pathology, Banff, Canada, 21-28 Apr, 2001.

Leukocyte replacement following human liver transplantation - donor kupffer cells persist long-term

Clouston, A., Powell, E., Lynch, S. V. and Jonsson, J. R. (2001). Leukocyte replacement following human liver transplantation - donor kupffer cells persist long-term. Asia Pacific Digestive Week 2001, Sydney, 23-27 Sep, 2001. Asia: Blackwell Science.

Maintenance of weight reduction after successful nutritional intervention in patients with fatty liver disease

Hickman, I., Jonsson, J. R., Clouston, A., Macdonald, G. and Powell, E. (2001). Maintenance of weight reduction after successful nutritional intervention in patients with fatty liver disease. Asia Pacific Digestive Week 2001, Sydney, Australia, 23-27 Sep, 2001. Asia: Blackwell Science.

Sinusoidal lymphocyte apoptosis is prominent following OLT - a potential mechanism for improved outcome of liver grafts

Clouston, A., Jonsson, J. R., Lynch, S. V. and Powell, E. (2001). Sinusoidal lymphocyte apoptosis is prominent following OLT - a potential mechanism for improved outcome of liver grafts. AASLD 52nd Annual Meeting, Dallas, Texas, USA, 9-13 Nov, 2001. Philadelphia: W B Saunders.

Sinusoidal lymphocyte apoptosis is prominent following OLT - a potential mechanism for improved outcome of liver grafts

Clouston, A., Jonsson, J. R., Lynch, S. V. and Powell, E. (2001). Sinusoidal lymphocyte apoptosis is prominent following OLT - a potential mechanism for improved outcome of liver grafts. Asia Pacific Digestive Week 2001, Sydney, 23-27 Sep, 2001. Asia: Blackwell Science.

Sinusoidal lymphocyte apoptosis is prominent following human liver trasplantation - A potential mechanism for improved outcome of liver grafts

Clouston, A. D., Jonsson, J. R., Lynch, S. V. and Powell, E. E. (2001). Sinusoidal lymphocyte apoptosis is prominent following human liver trasplantation - A potential mechanism for improved outcome of liver grafts. -, -, -. PHILADELPHIA: W B SAUNDERS CO.

Variable expression of housekeeping genes in human liver

Gochee, P., Jonsson, J. R., Clouston, A. and Powell, E. (2001). Variable expression of housekeeping genes in human liver. Asia Pacific Digestive Week 2001, Sydney, Australia, 23-27 Sep, 2001. Asia: Blackwell Science.

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

Jonsson, J. R., Powell, E., Ando, Y., Kelemen, L. and Clouston, A. D. (2000). Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model. Australian Gastroenterology Week 2000, Hobart, 18-21 Oct, 2000. Melbourne: Blackwell Scientific.

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

Jonsson, J. R., Ando, Y., Keleman, L., Clouston, A. D. and Powell, E. E. (2000). Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model. -, -, -. PHILADELPHIA: W B SAUNDERS CO.

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

Jonsson, J. R., Ando, Y., Kelemen, L., Clouston, A. D. and Powell, E. (2000). Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 Oct, 2000. Orlando, U.S.A.: WB Saunders.

Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient

Herzig, K., Falk, M., Jonsson, J. R., Axelsen, R., Griffin, A., Hawley, C. M., Cobcroft, R., Powell, E. and Johnson, D. W. (2000). Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient. 36th Annual Scientific Meeting of the A&NZ Society of Nephrology, Melbourne, 15-17 March, 2000.

The role of cytokine gene polymorphisms in acute rejection after liver transplantation

Hong, C., Powell, E. E., Balderson, G. A., Clouston, A. D., Purdie, D. M., Pandeya, N., Edwards-Smith, C. J., Stuart, K. A., Crawford, D. H., Fawcett, J., Lynch, S. V. and Jonsson, J. R. (2000). The role of cytokine gene polymorphisms in acute rejection after liver transplantation. -, -, -. PHILADELPHIA: W B SAUNDERS CO.

The role of cytokine gene polymorphisms in acute rejection after liver transplantation

Balderson, G. A., Clouston, A. D., Crawford, D. H., Edwards-Smith, C., Fawcett, J., Hong, C., Jonsson, J. R., Lynch, S. V., Pandeya, N., Powell, E., Purdie, D. M. and Stuart, K. A. (2000). The role of cytokine gene polymorphisms in acute rejection after liver transplantation. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 Oct, 2000. Orlando, U.S.A.: W. B. Saunders Co. Ltd..

The role of cytokine gene polymorphisms in acute rejection after liver transplantation

Jonsson, J. R., Cui, H., Powell, E., Pandeyer, N., Balderson, G. A., Clouston, A. D., Edwards-Smith, C., Stuart, K. A., Crawford, D. H., Fawcett, J., Lynch, S. V. and Purdie, D. M. (2000). The role of cytokine gene polymorphisms in acute rejection after liver transplantation. Australian Gastroenterology Week 2000, Hobart, Australia, 18-21 October, 2000. Melbourne: Blackwell Scientific.

The role of cytokine gene polymorphisms in renal impairment after liver transplantation

Jonsson, J. R., Hong, C., Isbel, N., Hawley, C., Butler, M., Purdie, D. M., Pandeva, N., Balderson, G. A., Clouston, A. D., Edwards-Smith, C. J., Lynch, S. V. and Powell, E. E. (2000). The role of cytokine gene polymorphisms in renal impairment after liver transplantation. -, -, -. PHILADELPHIA: W B SAUNDERS CO.

The role of cytokine gene polymorphisms in renal impairment after liver transplantation

Jonsson, Julie R., Hong, Cui, Isbel, Nicky, Hawley, Carmel, Butler, Maree, Purdie, David M., Pandeya, Nirmala, Balderson, Glenda A., Clouston, Andrew D., Edwards-Smith, C., Lynch, Stephen V. and Powell, Elizabeth E. (2000). The role of cytokine gene polymorphisms in renal impairment after liver transplantation. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 October, 2000. Hoboken, NJ: Wiley Interscience.

Weight reduction in patients with chronic hepatitis improves liver histology and biochemistry

Clouston, A. D., Jonsson, J. R., Shorthouse, C., Mori, T., Prins, J., Macdonald, G. and Powell, E. E. (2000). Weight reduction in patients with chronic hepatitis improves liver histology and biochemistry. 51st Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 27 - 31 October 2000. Hoboken, NJ, United States: John Wiley & Sons.

Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcome

Clouston, A., Powell, E., Balderson, G.A., Edwards-Smith, C., Hogan, P. and Lynch, S. V. (1999). Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcome. Transplantation Society of Australia and New Zealand 17th Annual Scientific Meeting, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Canberra: The Transplantation Society of Aust. and New Zealand.

Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells

Jonsson, J. R., Edwards-Smith, C. J., Hogan, P. G., Morotomi, Y., Clouston, A. D., Lynch, S. V., Strong, R. W. and Powell, E. E. (1998). Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons.

Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes

Jonsson, J. R., EdwardsSmith, C. J., Morotomi, Y., Hogan, P. G., Clouston, A. D., Lynch, S. V., Strong, R. W. and Powell, E. E. (1997). Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

Ldl Receptor and Hmg Coa Reductase Gene-Expression in Human Mononuclear-Cells Parallels That in Human Liver and Is Coordinately Regulated

Kroon, PA and Powell, EE (1992). Ldl Receptor and Hmg Coa Reductase Gene-Expression in Human Mononuclear-Cells Parallels That in Human Liver and Is Coordinately Regulated. DALLAS: AMER HEART ASSOC.

Measurement of Hmg Coa Reductase and Ldl Receptor Gene-Expression in Human Liver and Lymphocytes Invivo by Quantitative Pcr

Powell, EE and Kroon, P (1991). Measurement of Hmg Coa Reductase and Ldl Receptor Gene-Expression in Human Liver and Lymphocytes Invivo by Quantitative Pcr. PHILADELPHIA: W B SAUNDERS CO.

Steatohepatitis: comparison of alcoholic and non-alcoholic subjects with particular reference to portal-hypertension and hepatic complications

Crawford, D. H. G., Powell, E. E., Searle, J. and Powell, L. W. (1989). Steatohepatitis: comparison of alcoholic and non-alcoholic subjects with particular reference to portal-hypertension and hepatic complications. International Symposium on Portal Hypertension and Digestive Organs, Tokyo Japan, 25 February 1989. Richmond, VIC, Australia: Wiley-Blackwell Publishing.